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ABSTRACT 
The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPARs) are ligand-gated glutamatergic ion channels that mediate most 
excitatory neurotransmission in the brain. Alterations in AMPAR synaptic 
accumulation mediate synaptic plasticity, including long-term potentiation, 
long-term depression and homeostatic synaptic plasticity. AMPAR abundance in 
neurons is determined by balanced processes of protein translation and 
degradation. Changes in AMPAR function and trafficking have direct impacts on 
synaptic transmission and cognitive functions. However, the molecular 
mechanisms regulating AMPAR expression and dynamics in neurons remain 
largely unknown. In this thesis, two molecular mechanisms that regulate AMPAR 
translation and protein stability through two different signaling pathways, 5' 
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adenosine monophosphate-activated protein kinase (AMPK) and sirtuin 2 (SIRT2), 
are described. 
It is shown that SIRT2, a NAD+-dependent protein deacetylase, directly 
controls AMPAR stability by regulating AMPAR acetylation. For the first time, we 
discovered that AMPARs are subject to lysine acetylation, a novel form of 
post-translational modification for glutamate receptors. Under basal conditions, 
AMPARs are highly acetylated at their intracellular C termini, which protects 
against ubiquitination to antagonize AMPAR endocytosis and degradation, 
leading to prolonged receptor half-life. SIRT2 is also identified as the enzyme 
responsible for AMPAR deacetylation. Knockdown of SIRT2 led to elevated 
AMPAR acetylation and reduced ubiquitination, and consequently, increased 
AMPAR levels and synaptic transmission. SIRT2 knockout mice displayed 
weakened synaptic plasticity and impaired learning and memory.  
Resveratrol is a phytoalexin that has been shown to increase AMPAR 
expression and synaptic accumulation in neurons. The resveratrol effect on 
AMPAR expression is independent of sirtuin 1, the conventional target of 
resveratrol, but rather is mediated by AMPK and its downstream phosphoinositide 
3-kinase (PI3K)/Akt pathway. Application of the AMPK activator, 
5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR), to neurons 
ix 
 
mimics the effects of resveratrol on both signaling and AMPAR expression. The 
resveratrol-induced increase in AMPAR expression results from elevated protein 
synthesis through the AMPK-PI3K pathway activation. These studies describe 
novel regulatory mechanisms responsible for the control of AMPAR protein 
amount and subcellular distribution in neurons, providing insights into our 
understanding of synaptic plasticity, brain function and neurological disorders. 
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1.1 Introduction 
Normal brain function requires regulated signal transmission between pre- 
and post-synaptic terminals. Excitatory synaptic transmission is particularly 
important for cognitive function. In the brain, the majority of excitatory synaptic 
transmission in the vertebrate central nervous system (CNS) is mediated by 
glutamatergic receptors, which subsequently mediate synaptic plasticity and 
cognition. Glutamate receptors are ligand-gated ion channels using glutamate as 
the neurotransmitter to transmit excitatory signals in brain. Among the three 
subtypes of glutamatergic receptors, the 
α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor (AMPAR) 
conveys most of the fast synaptic transmission. AMPARs are considered the 
substrates of synaptic plasticity, including Hebbian-type plasticity (long-term 
potentiation, LTP or long-term depression, LTD) and homeostatic synaptic 
plasticity (HSP). Therefore, regulating AMPAR expression is crucial to maintain 
normal brain function and cognition. Aberrant regulation of AMPAR function or 
dynamics in the brain is directly associated with cognitive impairments like 
Alzheimer’s disease (AD) or dementia. Post-translational modifications (PTM) of 
proteins, such as phosphorylation, ubiquitination or palmitoylation, are important 
biochemical processes that regulate the functions and intracellular dynamics of 
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AMPARs. An AMPAR consists of four subunits (GluA1-4) with varied 
combinations. Previous studies have shown that phosphorylation of the GluA1 
subunit is essential for the formation of LTP in learning and memory, while 
palmitoylation of AMPARs controls their trafficking from the Golgi apparatus to the 
cell surface. Ubiquitination governs the proteolysis of AMPARs via the 
ubiquitin-proteasome system (UPS), directly affecting their intracellular stability. 
1.2 General overview of brain structure and synaptic transmission 
1.2.1 Basic structure of the brain and neurons 
The human brain is responsible for centralized control of the whole body as 
well as perceiving different senses such as vision, hearing, balance, taste and 
smell from the primary sensory organs. Brains, across all different species, are 
primarily composed of two classes of cells: neurons and glial cells. Neurons are 
highly specialized and electrically excitable cells that are responsible for 
information processing and transmission in the CNS. A typical human brain is 
thought to contain around 80 billion neurons (Azevedo et al., 2009). The highly 
complex neural network formed by neurons underlies the magnificent functions of 
the brain (Figure 1.1A). A neuron is composed of three basic units: an axon, the 
soma (cell body) and the dendrites (Squire et al., 2012a). During brain 
development, the axon of a neuron first outgrows the other neurites to reach the 
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axon-dendrite polarization (Amato et al., 2011). Thereafter, the axon spreads out 
to form connections with dendrites of other neurons and to generate the 
structures called synapses. A single axon is able to form several thousands of 
synapses with the dendrites of other neurons (Figure 1.1B) (Kandel et al., 2000).  
In addition to neurons, there is another large class of cells in the brain called 
glial cells. Glial cells have several subtypes in the CNS: astrocytes, microglia, 
oligodendrocytes, radial glia and ependymal cells (Cameron and Rakic, 1991). 
Even though not conducting direct signal transmission as neurons, glial cells still 
play crucial roles to maintain normal brain functions. For example, astrocytes 
support the neuron structure and metabolism while microglia are responsible for 
the immune reaction in the brain. Radial glia can guide the growth and migration 
of neurons during brain development (Squire et al., 2012b). Some studies show 
more regulatory functions that glial cells (e.g. astrocytes) may play, in addition to 
their traditional roles, in signal transduction in the brain, such as synaptic 
transmission and plasticity (Kang et al., 1998; Newman, 2003; Perea and Araque, 
2007; Rouach et al., 2008).  
1.2.2 Synaptic structure, function and signal transduction in brain 
Synapses are the basic units to connect all the neurons and build up the 
neural network in brain. Synapses are also the key interfaces to conduct the 
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signal transferring between two neurons. A synapse consists of three major 
components: pre-synaptic terminal (axon), synaptic cleft and post-synaptic 
terminal (dendrite). Both terminals contain extensive arrays of molecular 
machinery linking the two sites together and to carry out the signal transmission 
process in the brain. During signal transmission, the electrical signals are first 
transmitted from the axons of the presynaptic neurons to the synapses and trigger 
the release of neurotransmitters (e.g. glutamate, acetylcholine) into the synaptic 
clefts. Released neurotransmitter molecules subsequently bind to the specific 
receptors located on the postsynaptic terminals to induce cell membrane 
depolarization/hyperpolarization, depending on the type of the synapses, to pass 
the electrical signals on to the post-synaptic neurons. Synapses are the key 
structures in the brain to perform the complex electrical-chemical process of 
signal transmission between neurons (Figure 1.1C). Therefore, normal 
functioning of synapses is essential for proper brain functions. Aberrant synaptic 
functioning is largely involved in many nervous system disorders such as memory 
loss and dementia.  
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Figure 1.1 The gross structures of brain, neurons and synapses. 
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Figure 1.1 The gross structures of the brain, neurons and the synapses. (A) 
The gross morphology of a typical human brain. (B) The basic structure of a 
neuron: an axon, a soma and many dendrites. The axons of the pre-synaptic 
neurons project to the dendrites of the post-synaptic neurons to form synapses. 
(C) A typical glutamatergic synapse: when action potentials come from the 
pre-synaptic terminal (axon) to trigger the release of neurotransmitters into the 
synaptic cleft, which bind to the glutamatergic receptors on the post-synaptic 
terminal (dendrite) and induce membrane depolarization, to eventually induce 
action potential. 
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1.2.3 Glutamatergic receptors 
Glutamate (glutamic acid) is a major excitatory neurotransmitter while 
glutamatergic synaptic transmission is the major excitatory signaling in vertebrate 
CNS. Glutamate is also the precursor of gamma-aminobutyric acid (GABA), the 
main inhibitory neurotransmitter in the brain (Petroff, 2002). Glutamatergic 
transmission is mediated by two types of glutamate receptors: ionotropic and 
metabotropic glutamate receptors, which are mainly located at the postsynaptic 
surface of glutamatergic synapses and play crucial roles in many important brain 
functions such as: neural communication, synaptic plasticity, learning and 
memory formation.  
There are three subtypes of ionotropic glutamatergic receptors: AMPAR, 
N-methyl D-aspartate receptors (NMDAR) and kainate receptors (KARs). AMPA 
and NMDA receptors have gained extensive scientific attention in the past few 
decades given their important roles in normal nervous system development and 
functions, cognitive functions and disorders. Even though both primarily respond 
to glutamate, the roles that AMPAR and NMDAR play in the nervous system 
functioning are highly varied. Ionotropic AMPARs are primarily permeable to 
sodium ions while impermeable to calcium ions under basal condition while 
NMDARs are highly permeable to calcium ions that serve as the major signaling 
9 
 
molecules in nervous system. Therefore, AMPARs are mainly mediating the 
majority of fast excitatory synaptic transmission in the brain. In contrast, 
compared to AMPARs, NMDARs show relatively slower kinetics and its activation 
requires cell membrane depolarization to remove the magnesium clogging its ion 
channels. NMDARs are permeable to calcium ions that sense as a second 
messenger systems which is important in synaptic plasticity and certain 
neuropsychiatric disorders (Dingledine et al., 1999; Hollmann and Heinemann, 
1994). 
KARs are a group of ionotropic glutamate receptors that have been less 
studied compared to AMPAR and NMDAR. KARs were first identified as a distinct 
group of glutamate receptors through their selective activation by kainic acid 
derived from seaweeds. Similar to AMPAR and NMDAR, KAR also consists of 
different combinations of four subunits. Nevertheless, the ion channel 
conductance of KAR is very similar to AMPAR that is mainly permeable to sodium 
and potassium but not to calcium ions. KARs have been shown being involved in 
several nervous system disorders including seizures and epilepsy (Contractor et 
al., 2011; Fritsch et al., 2014; Huettner, 2003).  
In addition to the ionotropic glutamatergic receptors, there is another group of 
glutamatergic receptors that belong to the G-protein-coupled receptors (GPCR) 
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family that can be bound and activated by glutamate, called metabotropic 
glutamate receptors (mGluR). Similar to other GPCRs, mGluRs also have seven 
transmembrane domains that help them anchor on the cell membrane. However, 
unlike the ionotropic glutamate receptors, mGluRs are not ion channels that can 
mediate the fast influx or efflux of ions. Instead, mGluRs use G proteins as second 
messengers to exert their downstream physiological functions. There are eight 
different types of mGluRs (mGluR1-8) that can be divided into three groups: 
Group I, II and III. Group I mGluR can be activated by 3,5-dihydroxyphenylglycine 
(DHPG) and function mainly through the activation the intracellular calcium pool in 
endoplasmic reticulum (ER) (Shigemoto et al., 1997). Group II and III mGluRs 
function by activating a G protein that inhibits enzyme adenylyl cyclase that can 
form cAMP from ATP. mGluRs distribute widely in different regions of brain 
including cerebral cortex, hippocampus, cerebellum. They are located in both pre- 
and postsynaptic neurons and are broadly involved in many physiological 
processes in the brain such as synaptic plasticity, learning, memory, anxiety and 
pain perception (Platt, 2007).  
1.3 AMPARs 
1.3.1 Introduction to AMPAR structure and function 
AMPARs are tetrameric heteromeric complexes that consist of four 
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homologous subunits (GluA1-4). Each subunit has a large N-terminal extracellular 
domain, three transmembrane domains and a C-terminus intracellular tail (Figure 
1.2A). The extracellular and transmembrane domains of all subunits are very 
similar but vary in their intracellular cytoplasmic domains (Shepherd and Huganir, 
2007). GluA1, GluA4 and an alternative splice form of the GluA2 (GluA2L) have 
long cytoplasmic tails. The predominant splice form of GluA2 subunit has a short 
tail similar to GluA3 and an alternative splice form of GluA4 (GluA4S) (Shepherd 
and Huganir, 2007) (Figure 1.2B). These subunits combine in different 
stoichiometries to form distinct receptor subtypes (Dingledine et al., 1999; 
Hollmann and Heinemann, 1994). AMPA receptor subtype varies with cell type, 
development and brain region. For example, in hippocampal pyramidal cells, the 
majority of AMPA receptors are GluA1/A2 heteromers with a relatively minor 
fraction consisting of GluA2/3 heteromers, whereas the majority of AMPARs in 
Purkinje cells consist of GluA2–GluA3 heteromers (Lu et al., 2009; Song and 
Huganir, 2002; Wenthold et al., 1996). Under normal physiological condition, most 
AMPARs contain the GluA2 subunit, which blocks the calcium influx so that 
AMPARs are only permeable to sodium and potassium ions. Under certain 
physiological conditions in the nervous system, like synaptic plasticity, drug 
addiction and certain nervous system diseases, GluA2-lacking AMPA receptors 
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which are permeable to calcium ions can be generated to execute important 
signaling functions (Figure 1.3) (Hu et al., 2012; Kato et al., 2010; Mameli et al., 
2011; Man, 2011). Therefore, the regulation of subunit expression is critical in 
understanding both the normal and abnormal functioning of the nervous system.  
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Figure 1.2 Structure and the C-termini sequences of the AMPAR 
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Figure 1.2 Structure and the C-termini sequences of the AMPAR. This 
schematic cartoon shows the basic protein structure of an AMPAR GluA1 subunit 
(A, left) and the tetramer structure of a whole AMPAR being inserted on the cell 
membrane (A, right). The amino acid sequences of different AMPAR subunits 
(GluA1, 2 and 4) show different binding/targeting sites of their interacting proteins 
and kinases (e.g. PKA, PKC, CaMKII, AP-2) (B). Orange block: the conserved 
binding domain of protein 4.1N. Blue block: the conserved binding sequences of 
SAP97, RIL and PDZ-domain binding proteins. Purple block: the binding 
sequence of protein AP-2. Pink block: the binding sequence of protein NSF. 
Yellow block: the conserved binding sequences of proteins ABP/GRIP and PICK1.  
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Figure 1.3 Ion permeability of the AMPA receptor 
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Figure 1.3 Ion permeability of the AMPA receptor. Binding of agonists (e.g. 
glutamate) on the N-termini of AMPAR triggers its three-dimension conformational 
change, which opens the ion channel composed by the interior sides of four 
subunits. Under normal physiological condition, the ion channel of AMPAR is only 
permeable to the sodium ions (Na+) influx and potassium (K+) outflux. Under 
certain physiological or pathological conditions, the GluA2 subunit is removed to 
form GluA2-lacking AMPAR, which is also permeable to calcium (Ca2+) ions that 
serve important signaling functions in the brain.  
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1.3.2 Post-translational modifications of AMPAR 
    AMPAR subunits are subject to different types of post-translational 
modifications, such as phosphorylation on serines (S)/threonines (T), 
palmitoylation on cysteines (C), and ubiquitination on lysines (K). Most of the 
PTMs occur on the C-termini tails of the GluA1-4 subunits of AMPAR while few 
PTMs occur on intracellular domains (Lu and Roche, 2012a). For example, on 
GluA1 subunit, in addition to the phosphorylation sites on its C-terminus, only one 
phosphorylation site at S567 and another palmitoylation site at C585 of the “loop” 
domain have been identified (Figure 1.4).  
The best characterized PTM of AMPAR is S/T phosphorylation. AMPAR 
phosphorylation is an important regulatory mechanism that not only controls many 
aspects of AMPAR function itself, but also affects synaptic transmission, plasticity 
and higher level cognitive functions such as learning and memory formation (Lee, 
2006; Wang et al., 2005).  
Most of the identified phosphorylation sites of AMPAR are on GluA1, GluA2 
and GluA4 subunits. Among them, the effects of phosphorylation on GluA1 
subunit are best studied. In total five phosphorylation sites have been identified on 
GluA1 C-terminus tail: S567, S818, S831, T840, S845. S831 and S845 are the 
two phosphorylation sites that were identified first (Figure 1.4). S831 is 
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phosphorylated by protein kinase C (PKC) and Ca2+/calmodulin-dependent 
protein kinase II (CaMKII), which increases the single-channel conductance of 
AMPAR (Barria et al., 1997; Mammen et al., 1997; Roche et al., 1996). S845 is 
phosphorylated by protein kinase A (PKA) (Roche et al., 1996), which enhances 
the opening probability of AMPAR (Banke et al., 2000; Derkach et al., 1999). 
Single-point mutation on either S831 or S845 does not affect AMPAR insertion 
and LTP, however, double-mutation of these two sites together abolishes the 
expression of normal LTP (Hayashi et al., 2000; Lee et al., 2003). In contrast to 
LTP, LTD is crucially dependent on S845 but not S831. LTD is completely 
abolished in transgenic mice without phosphorylation on S845 (Lee et al., 2003). 
The other three phosphorylation sites, S818, T840 and S567 on GluA1 were 
recently reported (Figure 1.4). S818 and T840 are both phosphorylated by PKC 
(Boehm et al., 2006; Delgado et al., 2007; Lee et al., 2007) while S567 is 
phosphorylated by CaMKII (Lu et al., 2010). S818 phosphorylation enhances 
4.1N protein binding increased AMPAR exocytosis during LTP while the roles of 
T840 and S567 in synaptic plasticity is still unclear (Lin et al., 2009; Lu and Roche, 
2012b).  
For GluA2 subunit, three phosphorylation sites, S863, S880 and Y876 were 
identified on the short tail of GluA2 (Figure 1.2). S863 and S880 are 
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phosphorylated by PKC (McDonald et al., 2001) while tyrosine Y876 is 
phosphorylated by the Src family tyrosine kinases (Hayashi and Huganir, 2004). 
While the effects of S863 phosphorylation remain unclear, S880 and Y876 
phosphorylation mainly affects the protein interaction between GluA2 to 
PDZ-domain containing proteins. S880 and Y876 phosphorylation both disrupts 
the binding of ABP/GRIP, but not PICK1, to GluA2 subunit (Chung et al., 2000; 
Hayashi and Huganir, 2004; Matsuda et al., 1999).  
AMPAR palmitoylation and ubiquitination are relatively new discoveries that 
have started to gain extensive attention. Protein S-palmitoylation is a reversible 
process in which palmitic acid is covalently attached to intracellular cysteine 
residues of the protein substrates by palmitoyl acyltransferase (PAT), primarily 
mediated by a large DHHC (Asp-His-His-Cys) protein family (Fukata and Fukata, 
2010; Shipston, 2011). All four AMPA receptor subunits are being palmitoylated at 
two conserved sites, one within the pore domain (C585 on GluA1), and the other 
in the C-terminus juxtamembrane region (C811 on GluA1) (Hayashi et al., 2005). 
Palmitoylation on C585 of GluA1 subunit regulates the intracellular release of 
AMPAR from Golgi apparatus while palmitoylation on C811 inhibits the 
GluA1-4.1N protein interaction that regulates the stimulation-induced endocytosis 
of AMPAR  (Hayashi et al., 2005; Lin et al., 2009; Yang et al., 2009).  
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Ubiquitination is an evolutionally conserved posttranslational process that 
attaches a single ubiquitin or polymeric ubiquitin chain to lysine residues of a 
substrate protein that is catalyzed by a sequential action of three enzymes: the 
ubiquitin-activating enzyme (E1), the ubiquitin-conjugating enzyme (E2), and the 
ubiquitin ligase (E3)(Hicke and Dunn, 2003). Ubiquitination of membrane proteins 
functions as a tag to be recognized by the intracellular endocytic and proteolytic 
machineries (like proteosome or lysosome) for protein degradation (Nandi et al., 
2006; Schmitt, 2006). Both GluA1 and GluA2 subunits of AMPAR were found 
being ubiquitinated in neurons while the GluA1 ubiquitination is mediated by E3 
ligase Nedd4 (Lin et al., 2011; Lussier et al., 2011; Schwarz et al., 2010; Widagdo 
et al., 2015b). For GluA1, ubiquitination primarily occurs at K868 lysine residue on 
the C-terminus (Lin et al., 2011). Upon ubiquitination, along with the main stream 
proteasome pathway degradation, a small portion of internalized AMPAR will also 
be sorted into the lysosome pathway for degradation (Lin et al., 2011). Protein 
ubiquitination is also mutually exclusive with protein acetylation given that both 
processes occur on the same lysine residues. It has been shown that protein 
acetylation competes with ubiquitination while protein deacetylation facilitates 
ubiquitination (Caron et al., 2005). Cross-talk between protein acetylation and 
ubiquitination regulates the intracellular stability of proteins (Caron et al., 2005). 
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Figure 1.4 Major post-translational modifications sites identified on the 
GluA1 subunit of AMPAR.  
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Figure 1.4 Major post-translational modifications sites identified on the 
GluA1 subunit of AMPAR. So far, four PTMs of GluA1 have been identified: 
phosphorylation, palmitoylation, ubiquitination and acetylation. The majority of the 
PTMs are found at the C-terminus, or the intracellular “loop” domain of GluA1. 
Four major phosphorylation sites, S818, S831, T840 and S845 were identified on 
the C-terminus while two minor phosphorylation sites, C585 and S645 were 
identified on the first “loop” domain and the N-terminus respectively. Two 
palmitoylation sites, C585 and C811, were identified on the first “loop” domain and 
the C-terminus respectively. All the four lysines residues were identified as being 
ubiquitinated or acetylated (K831, K837, K840, K886).  
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1.4 AMPAR regulation and synaptic plasticity 
1.4.1 Hebbian-type synaptic plasticity and AMPAR regulation 
The Hebbian-type synaptic plasticity consists of two forms of plasticity: LTP 
and LTD. LTP refers to the long-lasting strengthened synaptic transmission 
triggered by certain patterns of neural activity, normally a train of high-frequency 
(100 Hz) electrical stimuli. Meanwhile, LTD is the opposite process of LTP, which 
produces persistent decrease of synaptic activity and can be induced by 
prolonged low-frequency (1 Hz) stimuli (Bear and Malenka, 1994; Malenka, 1994). 
The proper regulation of AMPAR phosphorylation, protein interaction and 
intracellular dynamics in neurons play integral roles in the induction and 
maintenance of LTP and LTD. On one hand, LTP requires fast synthesis and 
insertion of AMPARs onto the postsynaptic surface (Lu et al., 2001). On the other 
hand, fast internalization and endocytosis of AMPARs from the postsynaptic sites 
are needed for LTD (Shepherd and Huganir, 2007). Therefore, phosphorylation of 
S831 or S845 on GluA1 subunit by CaMKII or PKA respectively is of crucial 
importance for the induction of LTP (Lisman et al., 2002; Roche et al., 1996) while 
dephosphorylation of these two sites is required for LTD. Phosphorylation and 
dephosphorylation of these two sites are directly associated with the insertion and 
internalization of AMPAR from postsynaptic surface, respectively. Mutation of 
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these two sites (S831 and S845) on GluA1 results in failed induction of both LTP 
and LTD as well as loss of memory (Lee et al., 2003). In addition to 
phosphorylation, although it has not been experimentally demonstrated, 
ubiquitination and palmitoylation are expected to influence the LTP/LTD process 
as well given their important roles in the AMPAR internalization, degradation and 
trafficking from the ER to synapses during protein synthesis (Hayashi et al., 
2005).  
1.4.2 Homeostatic synaptic plasticity 
The brain has the amazing ability to adapt through its capability to change in 
response to experience and use. This fundamental property of plasticity serves to 
learn and remember complex tasks, obtain rewards, or even recover after injury. 
Surprisingly, with constant dynamic changes occurring in the brain, neuronal 
activity remains stable over an entire life span. Our brains appear to be 
constructed in such a manner that the mechanisms involved in learning and 
memory can be balanced by another distinct form of neuronal modulation, 
homeostatic plasticity. These two forms of plasticity (Hebbian-type and 
homeostatic) coexist to adapt to the changing sensory world while maintaining a 
balance within a physiological range (Davis, 2006; Marder and Goaillard, 2006; 
Turrigiano and Nelson, 2004). Typically, synaptic activity is strengthened when 
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neuronal firing is chronically suppressed or weakened when neuronal activity is 
chronically elevated. At both the whole cell and the entire network levels, activity 
manipulation leads to a global up- or down-scaling of the transmission efficacy of 
all synapses. However, the homeostatic response can also be induced locally at 
subcellular regions or individual synapses. Homeostatic synaptic scaling is 
expressed mainly via regulation of AMPA receptor trafficking and synaptic 
abundance. . 
Hebbian plasticity modulates neuronal networks, strengthening or weakening 
synapses in order to encode information. This form of plasticity is associative and 
can strengthen or weaken individual synapses through LTP and LTD. Given the 
positive-feedback nature of Hebbian plasticity, if a network were to go unchecked, 
this form of synaptic modulation could drive the network into an unstable state. If a 
large amount of LTP input went to one neuron it could reach saturation in firing. 
Conversely, if a large amount of LTD input occurred, the neuron could fall silent. 
Hebbian synaptic plasticity therefore necessitates distinct homeostatic 
mechanisms that can stabilize a network in the face of constant dynamic changes 
in synaptic strength. Indeed, neuronal networks use an array of homeostatic 
negative feedback mechanisms that allow neurons to assess their activity and 
adjust accordingly to remain within a homeostatic range.  
26 
 
Figure 1.5 Homeostatic regulation of synaptic AMPAR abundance 
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Figure 1.5 Homeostatic regulation of synaptic AMPAR abundance. Under 
basal conditions, a stable level of AMPARs at post-synaptic surface is maintained 
by balanced trafficking processes of receptor insertion and internalization (middle). 
High synaptic activity can be detected by neurons, leading to enhanced receptor 
internalization and reduced surface receptor localization (left). Conversely, when 
neurons are treated by long-term activity deprivation, higher levels of AMPARs are 
expressed at post-synaptic surface via enhanced receptor insertion, including 
both GluA2-containing and GluA2-lacking receptors (right).  During homeostatic 
regulation, the number of NMDARs at post-synaptic surface is not significantly 
altered under either condition. 
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1.5 Resveratrol: a phytoalexin that protects the nervous system 
Resveratrol (trans-3,4′,5-trihydroxystilbene) is a natural polyphenolic compound 
that is present at high levels in grape skin, red wine and nuts (Rocha-Gonzalez et al., 
2008). Resveratrol has been broadly used as a dietary supplement and shows 
beneficial effects on general health and cognitive function (Chung et al., 2012; Kodali 
et al., 2015; Witte et al., 2014) (Figure 1.6). Resveratrol has also been shown to 
protect neurons from cell death under several pathological conditions including 
glutamate-induced excitotoxicity (Chung et al., 2011), oxidative stress (Fukui et al., 
2010), ischemia and epilepsy (Wu et al., 2009). Importantly, resveratrol can 
ameliorate the symptoms associated with several neurodegenerative diseases 
including AD (Vingtdeux et al., 2008; Wang et al., 2008), Parkinson’s disease (PD) 
(Jin et al., 2008) and Huntington’s disease (HD) (Parker et al., 2005; Sinclair, 2005). 
Resveratrol is widely known as an activator of sirtuins (SIRTs), a class of 
NAD+-dependent protein deacetylases (Howitz et al., 2003; Smith et al., 2009). 
Among the seven members in SIRT family (SIRT1-7), SIRT1 is shown to be the 
primary target of resveratrol (Baur et al., 2006). SIRT1 activation is thought to underlie 
most of the beneficial effects associated with resveratrol (Baur and Sinclair, 2006). In 
addition, resveratrol has been shown to activate the metabolic regulator 5' adenosine 
monophosphate-activated protein kinase (AMPK) (Dasgupta and Milbrandt, 2007), 
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the primary bioenergy sensor responsible for the maintenance of cellular energy 
homeostasis (Hardie, 2007). 
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Figure 1.6 Chemical structure of resveratrol and its broad effects in age-related 
diseases.  
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Figure 1.6 Chemical structure of resveratrol and its broad effects in 
ageing-related diseases. Resveratrol is a small molecule natural polyphenol found 
in different plants. It has been shown to possess broad spectrum of protective effects 
to several aging-related diseases or dysfunction, such as obesity, AD and 
tumorigenesis. This figure is adopted and modified from Chung et al. 2012 (Chung et 
al., 2012).  
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1.6 Sirtuins and lysine acetylation 
 1.6.1 Lysine acetylation/deacetylation and its catalytic enzymes 
Lysine acetylation is one of the most ubiquitous and abundant PTMs of 
proteins in the cell. It refers to the biochemical process of adding acetyl functional 
groups to the lysine residues of polypeptides after their translation. Lysine 
acetylation was first identified on histones, which has been extensively studied for 
decades and well known to significantly affect chromatin structure and stability as 
well as gene transcription and expression (Allfrey et al., 1964; Grunstein, 1997). 
However, in recent years, acetylation of non-histone proteins has been found to 
play important roles in many physiological processes such as cell signaling, aging, 
metabolism, tumorigenesis, cognitive functions and neurological diseases (Black 
et al., 2008; Canto et al., 2009; Lu et al., 2011; Min et al., 2010; North et al., 2003; 
Rothgiesser et al., 2010).  
The lysine acetylation and deacetylation processes are usually accompanied 
by specific catalytic enzymes, depending on the protein substrates. The enzymes 
catalyze protein acetylation or deacetylation process are called histone 
acetyltransferases (HATs) or deacetylases (HDACs) respectively (Glozak et al., 
2005). In recent years, with the discovery of more non-histone substrates of 
acetylation and deacetylation, some researchers have started to call them KATs 
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(lysine acetyltransferases) and KDACs (lysine deacetylases), respectively (Lin et 
al., 2012).  
1.6.2 Family III HDACs: sirtuins 
The HDACs are classified into three groups (families I-III) based on their 
homology of the budding yeast (Saccharomyces cerevisiae) HDACs (Dali-Youcef 
et al., 2007). Sirtuins belong to the family III HDAC and are originally named after 
the silent information regulator 2 (Sir2) gene that regulates the mating type of the 
yeast (Klar and Fogel, 1979). Different from the family I and II HDACs, which use 
Zn2+ as the cofactor, sirtuins are dependent on nicotine adenine dinucleotide 
(NAD+) to exert their catalytic functions. Mammalian sirtuins (SIRT1-7) are 
characterized by a hallmark domain of about 260 amino acids shared by all the 
seven members, which binds to both NAD+ and acetyl-lysine residues (North and 
Verdin, 2004). (Figure 1.7). Mammalian sirtuins can be divided into four classes 
(I-IV) based on the phylogenetic relationship of their sequences. SIRT1, 2, 3 
belong to class I, while SIRT4 and 5 belong to class II and III respectively. SIRT 6 
and 7 belongs to class IV sirtuin (North and Verdin, 2004). Sirtuins also localize 
very differently in the cell. SIRT1 primarily localizes in the nucleus with a small 
portion in the cytosol while SIRT2 is predominately expressed in the cytosolic 
space. SIRT3, 4, 5 are uniquely localized in mitochondria while SIRT6 is only 
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present in the nucleus. SIRT7 mainly expresses in the nucleolus (Haigis and 
Sinclair, 2010). Sirtuins have been extensively studied for their regulatory roles in 
gene transcriptional repression, recombination and cell-cycle division, which are 
all associated with the chromatin structure recomposition. Nevertheless, in recent 
years, more non-histone substrates of sirtuins, such as tubulin, tau, p300, p53, 
NF-kB, have been identified and found broadly involved in basic brain functions 
as well as nervous system diseases (Black et al., 2008; Min et al., 2010; 
Rothgiesser et al., 2010).  
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Figure 1.7 Basic structures, molecular weights and subcellular localizations 
of human sirtuins (SIRT1 – 7).  
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Figure 1.7 Basic structures, molecular weights and subcellular localizations 
of human sirtuins (SIRT1-7). All sirtuins contain an evolutionarily conserved 
NAD+-dependent deacetylase (DAC) domain or a mono-ADP-ribosyl transferase 
(ART) domain, or both, which is the basis of their catalytic functions. This domain 
is flanked by an N-terminal and a C-terminus sequence with varied lengths that 
determine the subcellular localization of sirtuins (e.g. nucleus, cytoplasm or 
mitochondria). This figure is adopted and modified from Michan et al., 2007 . 
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1.7 Investigating new regulatory mechanisms of AMPAR in neuron 
 Regulation of intracellular synthesis, degradation and trafficking of AMPAR is 
one of the most important physiological processes in neurons that show direct 
influences on synaptic activity, transmission and plasticity as well as the 
upper-level cognitive functions such as learning and memory. Understanding the 
detailed molecular mechanism of AMPAR regulation in the brain can greatly help 
us to further understand the mechanism of cognition and memory, as well as 
assist us in developing novel therapeutic techniques or drugs to rescue cognitive 
deterioration-related nervous system diseases such as dementia and AD.  
 In this thesis, I aimed to understand in more depth about the molecular 
mechanism of AMPAR regulation in neurons. The first question I investigated is 
the potential regulatory roles that sirtuins may have on AMPAR. As one of the 
highly expressed protein deacetylases in neurons, as well as a gene broadly 
involved in aging-related processes, I investigated whether sirtuins may play 
regulatory roles on AMPARs. The second question I asked is whether resveratrol, 
and its downstream targets such as AMPK and SIRT1, may exert their 
physiological effects through their interaction with AMPARs. Understanding this 
relationship can help us understand the promiscuous physiological functions of 
this widely used food supplement and make a better use of it.  
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CHAPTER TWO 
Experimental materials and methods 
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2.1 Cell culture 
2.1.1 Primary culture of rat embryonic neurons  
Cortical and hippocampal brain tissues were dissected out respectively from 
embryonic day 18 Sprague Dawley rat (Charles River) brains of either sex and 
prepared for primary culture. Tissues were first incubated in digestion solution (14 
ml HBSS, 0.15 ml 500 mM EDTA pH 8.0, 0.5 ml 4mg/ml L-cysteine, 0.5 ml 
15mg/ml papain) at 37℃ for 20 minutes, then gently tritu rated with a Pasteur 
pipette in trituration buffer (0.1% DNase, 1% ovomucoid/1% bovine serum 
albumin in HBSS) until neurons were fully dissociated. Dissociated cortical 
neurons were then counted using a hemocytometer and plated into either 6-well 
plates (1 X 106 neurons per well) or 60 mm Petri dishes (3 X 106 neurons per 
dish)(Greiner Cellstar). Hippocampal neurons (0.3 – 0.8 X 106) were plated on 
18mm circular coverslips (Carolina, 0.1mm thick) in 60 mm Petri dishes (5 
coverslips/dish). Both dishes and coverslips were coated with poly-L-lysine 
(Sigma-Aldrich, 100 μg/ml in Borate buffer) overnight at 37℃ then washed three 
times with sterile distilled water and left in plating medium [MEM (500 mL) 
containing 10% fetal bovine serum (FBS), 5% horse serum (HS), 31 mg 
L-cysteine, and 1% penicillin/streptomycin and L-glutamine mixture (1% P/S/G)] 
before cell plating. Plating medium was replaced by feeding medium (Neurobasal 
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medium supplemented with 1% HS, 2% B-27 and 1% P/S/G) the day after cell 
plating. Neurons were maintained in feeding medium with fluorodeoxyuridine 
(FDU, 10 μM) supplemented at DIV5 to suppress glial growth until experimental 
use. 
2.1.2 Culture of human embryonic kidney cell line (HEK293A/T) 
 Frozen HEK293A/T cell line was long-term stored in either -80℃ or liquid 
nitrogen. To thaw the frozen cell line, an aliquot of cells was left at room 
temperature for 1 minute then transferred to 37℃ water bath for another 2 
minutes until fully thawed. Thawed cells were placed into a 10 cm diameter cell 
culture dish (Greiner Bio-One) containing 10 ml pre-warmed HEK cell culture 
medium [Dulbecco’s modified eagle medium (DMEM, Invitrogen) supplemented 
with 1% penicillin/streptomycin, 10% fetal bovine serum and 1% L-Glutamine]. 
The dish was left in tissue culture incubator at 37℃  with 5% CO2 for 
approximately an hour. After more than 90% of the cells settled down, the old 
culture medium was replaced with new, pre-warmed medium to clean up the toxic 
solvent dimethyl sulfoxide (DMSO, Sigma-Aldrich) used for cell storage. The cells 
confluency was checked daily until it reached the percentage you need for 
experiments.  
 HEK 293A/T Cells were generally split at the confluency of 80% to ensure 
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their healthiness for experiments. When splitting the cells, the old medium was 
first removed and placed aside in a 50 mL polypropylene centrifuge tube (ITI 
Scientific) for later use. 2 mL trypsin-EDTA (Invitrogen) was added right after and 
incubated at 37℃ for 1 minute to remove adherent cells from the bottom of the 
culture dish. Then the old medium was added back to the dish to neutralize the 
trypsin reaction. Cells were spun down at 1,100 revolutions per minute (rpm) for 3 
minutes at room temperature (RT) and the old medium was discarded. Pellet of 
cells were resuspended in fresh culture medium and evenly distributed to 60mm 
culture dishes for further experiments. Cells were reseeded at proper 
concentration to a new culture dish then reincubated at 37℃.  
 To freeze HEK cells for future use, 80%~ confluency cells were trypsinized 
and isolated as described above. Cells were then resuspended in “Ice medium” 
(DMEM supplemented with 10% FBS and 1% L-glutamine) and aliquoted into 
Nalgene cryovial and slowly frozen in -20℃ for one hour after transferred to -80℃ 
for long-term storage.  
2.2 Protein techniques 
2.2.1 Immunoblotting and biochemistry 
Two week old cortical neurons cultured in either 60 mm or 6-well plates were 
treated by resveratrol, AICAR or other chemicals as stated. For 
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blockade/occlusion experiments, unless specifically stated, the cells were 
pre-treated for one hour prior to resveratrol treatment then remained in the bath 
until cell lysis. Cells in control groups were treated with the appropriate vehicle 
solvents (saline or DMSO). After treatment, neurons were lysed in Laemmli 2X 
sample buffer (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% 
bromophenol blue, 0.125 M Tris HCl) and boiled for 10 minutes at 95℃ for SDS 
page electrophoresis. After separation in SDS page, proteins were transferred to 
PVDF immunoblotting membrane (Bio-rad) and probed for different targets with 
the stated antibodies. Immunoblots were visualized using a chemiluminescence 
detection system (GE Healthcare) and exposed to Fuji medical X-ray films (Fisher 
Scientific), scanned and analyzed using the NIH ImageJ program. 
2.2.2 Immunoprecipitation (IP) 
 Brain tissues or cultured neurons were lysed in 1X 
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4; 50 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1-1% SDS) supplemented with 
protease inhibitor cocktail tablets (11697498001, Roche) to minimize protein 
degradation. Stringent RIPA buffer (1% SDS) was used in IP experiments to 
ensure clean protein immunoprecipitation while mild RIPA buffer (0.1% SDS) was 
used in Co-IP experiments for protein-protein interaction assays. Cell lysates 
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were then incubated with specific antibodies for 1 hour then another 4 hours with 
protein A-agarose beads (sc-2001, Santa Cruz Biotechnology). Agarose beads 
were then washed with NP-40 buffer (25 mM Tris-HCl, pH 7.4; 150 mM NaCl, 1 
mM EDTA, 1% NP-40) for at least three times to ensure a clean 
immunoprecipitation. Thereafter, the agarose beads were boiled with Laemmli 2X 
sample buffer (4% SDS, 10% 8 2-mercaptoethanol, 20% glycerol, 0.004% 
bromophenol blue, 0.125 M Tris HCl) for 10 minutes at 95℃ before being 
subjected to immunoblotting analysis. 
2.2.3 Immunoblotting (IB) 
Samples of whole tissue/cell lysis, IP or Co-IP, were prepared for 
immunoblotting by boiling in 2X Laemmli sample buffer (4% SDS, 10% 
2-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, 0.125 M Tris HCl) 
for 10 minutes at 95°C to denature all proteins then stored at -20℃. After resolved 
by SDS-page electrophoresis, proteins were transferred to a PVDF membrane 
and probed with specific primary antibodies. 8 – 15% SDS-page gels were used in 
electrophoresis depending on the molecular weights of the target proteins. 
Experiments involve immunoblotting were all repeated at least 3 times or more to 
ensure the reproducibility and consistency of the results. 
2.2.4 In vivo/in vitro acetylation assay 
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 To detect the acetylation signal of endogenous AMPARs in brain (in vivo) 
or recombinant receptor protein overexpressed in HEK 293T cells (in vitro), the 
GluA1 subunit was first immunoprecipitated with a specific antibody by Protein 
A-agarose beads from the whole brain extracts or homogenized 293T cells 
lysates. The lysis buffer (RIPA buffer with 1% SDS) used to homogenize the brain 
tissue has been supplemented with 100 μM trichostatin A, 50 mM sodium butyrate 
and 50 mM nicotinamide to sufficiently block deacetylases activity. The acetylation 
signal was then assessed by immunoblotting with an antibody that detects 
general acetylated lysine residues (ab80178, Abcam). 
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Table 2.2.1 Buffers used in protein manipulations 
 
Name      Components (for 1L)   pH adjustment 
10X Tris-buffered saline 0.2 M Tris base     adjust pH to7.6 
(10X TBS)     1.37 M Sodium chloride   
       38 ml 1M Hydrochloric acid   
1X TBST     0.1% Tween-20 (v/v) in 1X TBS 
10X Tank buffer   0.25M Tris      no need to adjust 
       1.92M Glycine 
       0.1% SDS 
10X Transfer buffer   48 mM Tris base    adjust pH to 8.3 
       38 mM Glycine 
       0.37g SDS 
       20% Methanol 
4X Separating gel buffer 1.5M Tris-HCl     adjust pH to 8.8 
4X Stacking gel buffer  0.5M Tris-HCl     adjust pH to 6.8 
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2.3 Cell techniques 
2.3.1 Immunocytochemistry 
Low density (54,000/coverslip) hippocampal neurons were washed once in 
ice-cold artificial cerebrospinal fluid (ACSF) and fixed for 10 minutes in 4% 
paraformaldehyde / 4% sucrose solution on ice. To stain total protein, cell 
membranes were permeabilized for 8 minutes in 0.3% Triton-X-100 
(FisherBiotech) in phosphate buffered saline (PBS), rinsed three times in 1X PBS 
then subjected to a blocking procedure (1-hr in 10% goat serum PBS). To stain 
surface protein, cells were blocked in goat serum without permeabilization. After 
blocking, cells were incubated with primary antibodies (in 5% goat serum PBS) for 
2 hours, washed and incubated with Alexa Fluor-conjugated fluorescent 
secondary antibodies (1:700, Life Technologies) for an additional hour. Cells were 
then mounted to microscopy glass slides with ProlongGold anti-fade mounting 
reagent (Life Technologies) for subsequent visualization. 
2.3.2 Transfection of neurons or HEK cells.  
Hippocampal neurons cultured on 18 mm coverslips at 11 days in vitro (DIV) 
were transferred to a 12-well plate and transfected by Lipofectamine 2000 (Life 
Technologies) with target plasmid DNA or siRNA per the manufacturer’s 
suggestion. For one coverslip, 0.9 µL Lipofectamine 2000 and 1 µg plasmid DNA 
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or siRNA (0.7µg DNA/siRNA plus 0.3µg EGFP) were first separately diluted in 50 
µL 1X MEM medium then mixed and incubated at room temperature for 20 
minutes to form the transfection complex. The transfection complex was added to 
the coverslips in 500 µL feeding medium per well and incubated at 37℃ for 4 
hours before the medium was removed and replaced by new feeding medium. 
New feeding medium was half-to-half mixed with old feeding medium in the dish 
to avoid neurotoxicity. Neurons were then cultured 3 more days for the target 
proteins to express. Neurons were fixed and subjected to a standard 
immunocytochemistry protocol. HEK cells were cultured and split into 6-well 
plates (1 million/well) to grow overnight prior to transfection. The transfection 
process for HEK cells is identical to that described for neurons except that 4 µL 
Lipofectamine 2000 was mixed with 4 µg target plasmid to transfect each well of 
cells. Medium was changed 4 hours post-transfection and HEK cells were further 
cultured an additional 24 hours to ensure target protein expression before cells 
were harvested for Western blot analysis. HEK cells were cultured in the following 
medium: 1X DMEM with 10% FBS, 1% P/S and 1% L-Glutamine. 
2.3.3 Live neuron imaging.  
For G-CaMP3 imaging in live neurons, a plasmid containing the cDNA of 
G-CaMP3 was transfected into DIV 11 hippocampal neurons followed by 3 days of 
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incubation to ensure G-CaMP3 protein expression prior to imaging. One coverslip 
with cultured neurons was placed into a sealed live imaging chamber and 
maintained at 37℃ on a temperature controller (Tempcontrol 37-2 digital) for the 
duration of the imaging session. Imaging duration of one coverslip was restricted 
to no longer than 30 minutes to ensure the health of neurons. An inverted Carl 
Zeiss fluorescent microscope was used to collect all the images. A 63× 
oil-immersion objective (numerical aperture, 1.4) along with the AxioVision 
software (release 4.5) were used to take pictures of the neurons. 
2.3.4 Cell surface protein biotinylation assay 
Two-week old cortical neurons were treated with resveratrol (40 μM) at 37℃ 
before performing cell surface protein biotinylation assay. After treatment, neurons 
were rinsed by ice-cold 1X ACSF once then incubated with EZ 
link-sulfo-NHS-LC-biotin (Thermo Scientific) dissolved in 1X ACSF (1 mg/ml) for 
10 minutes at room temperature and another 20 minutes at 4℃. After thoroughly 
rinsing by 1X ACSF to get rid of extra biotin, neurons were lysed in lysis buffer 1 
(1X PBS with 0.5% SDS, 0.5% DOC, 1% Triton-X-100) with the presence of 
protease inhibitor cocktail (Roche), sonicated, then rotated at 4℃ for 30 minutes 
to achieve thorough cell lysis. After spinning down at 13,000 rpm for 15 minutes, 
1/10 supernatant was mixed with equal volume Laemmli 2X sample buffer, boiled 
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10 minutes at 95℃ and ready for western blot analysis. The rest of supernatant 
was removed to a new Eppendorf 1.5ml tube containing 40 μL pre-equilibrated 
Avidin beads (Thermo Scientific) while the pellet was discarded. Avidin beads 
along with the supernatant were rotated at 4℃ for at least two hours or overnight. 
The beads were rinsed three times in 1X PBS (with 0.5% Triton-X-100), before 
being mixed with equal volume Laemmli 2X sample buffer and boiled 10 minutes 
at 95℃ in preparation for western blot analysis. 
2.3.5 AMPA receptor internalization assay 
 After drug treatment, neurons were incubated with GluA1Nt antibody 
(1:100, Millipore) at 37℃ for 10 minutes then washed three times with feeding 
medium to get rid of extra antibody. Neurons were then treated by AMPA (100 μM, 
1 minute) to rapidly induce drastic AMPAR internalization. After rinsing off extra 
AMPA from the medium, neurons were further incubated with a high concentration 
of secondary antibody (Alexa Fluor® 555 dye, 1:80) for 10 minutes to occupy all 
AMPARs remaining on the cell surface. Thereafter, neurons were rinsed in 1X 
ACSF then fixed in 4% paraformaldehyde/4% sucrose solution for 10 minutes. 
Neurons were then permeabilized with 0.3% Triton-X-100 PBS and incubated with 
a lower concentration of secondary antibody (Alexa Fluor® 488 dye, 1:700) for 45 
minutes to specifically label the internalized AMPARs. 
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2.4 Immunofluorescence microscopy 
Mounted coverslips were stored in the dark at 4℃ for no longer than a week 
before fluorescence microscopy. An inverted Carl Zeiss fluorescent microscope 
was used to collect all the images. A 63× oil-immersion objective (numerical 
aperture, 1.4) along with the AxioVision software (release 4.5) were used to take 
pictures of the neurons. The exposure duration of the fluorescence signal was 
established manually to ensure that it was within the full dynamic range by using a 
glow scale look-up table. For each experiment, images of at least 15 neurons per 
group were randomly taken and used for quantification. NIH Image J software 
was used for the image quantification. 
2.5 Hippocampal slice preparations  
Mice of either sex were sacrificed by isoflurane anesthesia at age 6~8 wks. 
Brains were quickly removed and submerged in ice-cold oxygenated 
sucrose-replaced 1X ACSF cutting solution containing (in mM) 206 sucrose, 2 KCl, 
2 MgSO4, 1.25 NaH2PO4, 1 CaCl2, 1 MgCl2, 26 NaHCO3, 10 D-glucose, pH 7.4, 
315 mOsm. Transverse slices (350 μm thick) were cut with a vibratome from the 
middle portion of each hippocampus. After dissection, slices were incubated in 
ACSF containing (in mM): 124 NaCl, 2 KCl, 2 MgSO4, 1.25 NaH2PO4, 2.5 CaCl2, 
26 NaHCO3, 10 D-glucose, pH 7.4, 310 mOsm, in which brain slices were allowed 
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to recover for at least 90 minutes before recording. A single slice was then 
transferred to the recording chamber and submerged beneath continuously 
perfused ACSF saturated with 95% O2 and 5% CO2. Slices were incubated in this 
chamber for 20 minutes before stimulation at room temperature. This part of 
experiments were performed by collaborators in Dr. Dennis Selkoe’s lab at Center 
for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical 
School (Boston, MA).  
2.6 Electrophysiology  
Standard field excitatory postsynaptic potentials (fEPSP) were recorded in the 
CA1 region of the hippocampus. A bipolar stimulating electrode (FHC Inc., 
Bowdoin, ME) was placed in the Schaffer collaterals to deliver test and 
conditioning stimuli. A borosilicate glass recording electrode filled with ACSF was 
positioned in the stratum radiatum of CA1, 200~300 µm from the stimulating 
electrode. fEPSP in CA1 were induced by test stimuli at 0.05 Hz with an intensity 
that elicited a fEPSP amplitude of 40~50% of maximum. Test responses were 
recorded for 30-60 minutes prior to beginning the experiment, to ensure stability 
of the response. To induce LTP, two consecutive trains (1 s) of high frequency 
stimulation (HFS) at 100 Hz separated by 20 seconds, a protocol that induces 
LTP lasting ~1.5 hours in wild-type mice were applied to the wild-type or Sirt2-/- 
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slices. To induce LTD, 900 pulses at low frequency (1 Hz) stimulation (LFS) were 
applied to the slices. All LTP and LTD values represent fEPSP slopes measured 
60 minutes after the conditioning stimulus, unless stated otherwise. The field 
potentials were amplified 100x using an Axon Instruments 200B amplifer and 
digitized with a Digidata 1322A digitizer. The data were sampled at 10 kHz and 
filtered at 2 kHz. Traces were obtained by pClamp 9.2 and analyzed using 
Clampfit 9.2. This part of experiments were performed by collaborators in Dr. 
Dennis Selkoe’s lab at Center for Neurologic Diseases, Brigham and Women’s 
Hospital and Harvard Medical School (Boston, MA). 
For miniature excitatory postsynaptic current (mEPSC) recordings, 2-week 
old cultured hippocampal neurons on coverslips were first treated with resveratrol 
(40 μM) for 4 hours, then transferred to a recording chamber with extracellular 
solution containing 140mM NaCl, 3 mM KCl, 1.5 mM MgCl2, 2.5mM CaCl2, 11mM 
glucose, and 10mM Hepes (305 mOsm, pH 7.4), which was supplemented with 
tetrodotoxin (TTX, 1 μM) to block action potentials, 
(2R)-amino-5-phosphonovaleric acid (APV, 50 μM) to block NMDARs and 
bicuculline (20 μM) to block GABAA receptor-mediated miniature inhibitory 
postsynaptic current (mIPSCs). Whole-cell voltage clamp recordings were made 
with patch pipettes filled with intracellular solution containing 110 mM 
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Cs-methanesulfonate, 10 mM CsCl, 10 mM Hepes, 0.2 mM EGTA, 4 mM Mg-ATP, 
0.3 mM Na2-GTP, and 10mM sodium phosphocreatine (295 mOsm, pH 7.4), with 
the membrane potential clamped at −70mV. Recordings started 5 minutes after 
establishing whole-cell configuration to ensure equilibration between the pipette 
solution and the cytosol. mEPSCs were recorded with an Axopatch 200B amplifier 
and displayed and recorded digitally on a computer for subsequent off-line 
analysis with Clampfit. 
2.7 Neuronal cell image collection and analysis.  
Mounted coverslips were kept in the dark at 4℃ before imaging. Using a Carl 
Zeiss inverted fluorescent microscope, neuronal cell images were collected with a 
63× oil-immersion objective (numerical aperture, 1.4) and collected with 
AxioVision Release 4.5 software. The exposure time of the fluorescence signal 
was adjusted manually to ensure that the signal intensity was within the full 
dynamic range by using a glow scale look-up table. Once an exposure time was 
established, it was used throughout the duration of the image collection process 
for all samples. Neuron images were quantified using NIH ImageJ. For 
quantification, GluA1 puncta ranging in size from 5 - 20 pixels were first selected 
using a thresholding function before both mean puncta size and intensity were 
automatically measured. GluA1 total intensity was calculated by multiplying the 
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value obtained for mean puncta size by the value obtained for fluorescence 
intensity. 
2.8 Reverse transcription polymerase chain reaction (RT-PCR).  
After treatment, total RNA from cultured cortical neurons was isolated using 
the QIAamp RNA Blood mini kit (Qiagen). The same amount of RNA (500 ng) 
from each sample was reverse-transcribed to cDNA with 0.5 μg oligo(dT)12-18 
primer, 200 μM dNTP, 100 mM DTT and 200 units of SuperScriptTM II Reverse 
Transcriptase (Life Technologies) following the manufacturer’s instructions. 
RT-PCR was then performed with the following primers: GluA1: 
GCTTCATGGACATTGACTTA and ATCTCAAGTCGGTAGGAGTA (a 673 base 
pairs fragment); GAPDH: TGAAGGTCGGTGTGAACGGATTTGGCCG and 
CCATGTAGGCCATGAGGTCCACCACCC (a 983 base pairs fragment). GAPDH 
was used as the internal control for GluA1. The RT-PCR products were then 
subject to 1% Agarose gel electrophoresis, imaged and quantified with NIH 
ImageJ program. 
2.9 Golgi impregnation 
Golgi impregnation of whole brains from C57BL/6J wild-type and SIRT2 
knock-out mice were performed with the FD Rapid GolgiStainTM Kit (FD 
NeuroTechnologies, Inc), following the manufacturer’s protocol. Briefly, mice of 
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either sex at 12-15 weeks of age were paralyzed in a 4% CO2 chamber for 5 
minutes then the brains were immediately removed and rinsed in MilliQ water. 
Brains were retrieved and immersed in a Golgi-Cox solution containing potassium 
dichromate, mercuric chloride, and potassium chromate. The mixture of solutions 
was replaced once after 6 hours of initial immersion, then stored at room 
temperature in darkness for 2 weeks. After the immersion period in the Golgi-Cox 
solution, the embedded brains were transferred to a cryoprotectant solution and 
stored at 4°C for at least 1 week in the dark before cutting. Brain slices were 
sectioned in the coronal plane at approximately 300 µm thickness on a vibratome. 
Brain slices were transferred onto gelatin-coated slides and were air dried at room 
temperature in the dark overnight before further processing. After drying, sections 
were rinsed with distilled water and stained in a developing solution and 
subsequently dehydrated with 50%, 75%, 95%, and 100% ethanol. Finally, the 
sections were defatted in xylene substitute and mounted on coverslips with 
Permount mounting liquid (Fisher Scientific). Images were acquired with a Carl 
Zeiss Axiovert 200M microscope and AxioVision software (release 4.5). Each 
neuron was scanned under high magnification (63x, oil immersion, NA = 1.4) by 
varying the depth of the Z plane, to ensure that all parts of the cell (especially 
dendrites) were intact. The number and size of apical and basal spines, and the 
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length of dendrites on hippocampal CA1 pyramidal neurons was measured blind 
to the genotype with Image J software. At least 20 neurons were selected from the 
CA1 region in each condition. 
2.10 Behavioral tests 
2.10.1 Fear conditioning test 
 The fear conditioning test consisted of two parts: context- and tone-dependent 
fear conditioning (Figure 2.1). Before the test, mice were habituated in a separate 
cage with similar context as the testing cage (bars on the floor, white and smooth 
walls, pine wood bedding with an 8% acetic acid odor) for three continuous days 
(5 minutes/day). On experiment day 1, in each trial, one mouse was placed into 
the testing cage and allowed to explore the cage freely for 3 minutes, followed by 
a 30 seconds tone (80 decibals) and an electrical foot shock (2 seconds, 0.6 mV) 
at the end of the tone. The tone and foot shock were repeated three times in each 
trial with three 1-minute intervals. The procedure was repeated for every mouse in 
the experiment. The whole cage was thoroughly cleaned up with 70% ethanol and 
8% acetic acid after every mouse to avoid potential olfactory distraction from other 
individuals. On experiment day 2, the mice were placed back into the same cage 
with exactly the same environment and odor to test their contextual fear memory 
without any foot shock. The mice were allowed to explore the cage for 5 minutes. 
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On day 3, the context of the cage was completely changed (smooth floor, wall 
decorated by dots, corn bedding with 20% vanilla odor) and the mice were 
allowed to explore the cage freely for 3 minutes then another 2 minutes with the 
same tone played. The motion index and freezing percentages of the mice were 
recorded and analyzed by Video Freeze® system (Med Associates Inc.). 
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Figure 2.1 The protocol of fear conditioning behavior test of memory. 
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Figure 2.1 The protocol of fear conditioning behavior test of memory. (A) 
The mouse subject to the test was pre-exposed and trained not to fear for the 
experimental environment for three days before the fear conditioning. (B) On the 
first experimental day, the subject mouse was left to move free in the cage for the 
first three minutes as the baseline recording, then three 2-second electrical 
shocks accompanied by 30-second sound cues were delivered to the subjects 
with 1 minute intervals. (C) On the second experimental day, to measure the 
contextual memory, the subject mouse was left to move free in the cage with 
training context for 5 minutes. (D) To measure the tone-dependent fear memory, 
on the third day of the test, the training context of the cage has been replaced with 
novel context, and the mouse was left to move free in the cage for a total 5 
minutes with the presence of the same tone on day 1 for the last 2 minutes.  
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2.10.2 Novel object recognition test 
 The novel object recognition test protocol was adopted and modified from 
elsewhere (Gao et al., 2010). Briefly, the mice were habituated one by one in an 
open field arena (45 cm × 45 cm × 30 cm, made by PVC boards) for 3 continuous 
days (Day 1-3), 5 min per day (Figure 2.2). On the fourth day (Day 4), three 
identical blue-colored flasks (50 mL) were placed into the arena. The mice were 
trained repeatedly for 4 times on Day 4 to recognize these flasks. Each training 
session lasted 5 minutes. The object memory was probed on the fifth day (Day 5) 
when one flask was replaced by a yellow-colored beaker with similar size as the 
flask (50 mL). The arena was thoroughly wiped with 75% ethanol to clean any 
odor cues between mice throughout all the sessions. The number of explorations 
(nose pokes) of the mice to each object were scored by experienced observers 
and expressed by the discrimination index (DI): DI = [(Nnovel – Nfamiliar1) + (Nnovel – 
Nfamiliar2)] / Ntotal. Where Nnovel refers to the number of times the mice explored 
the newly introduced object (yellow beaker), while Nfamiliar1 and Nfamiliar2 refer 
to the number of explorations of the other two old objects (blue flasks). Ntotal is 
the total number that all three objects were explored on the probe day.  
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Figure 2.2 The novel object test for mouse learning memory. 
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Figure 2.2 The novel object test for mouse learning memory. (A) The mouse 
was habituated for 3 continuous days (Day 1-3) in the test arena (45cm x 45cm x 
30cm). (B) On experimental Day 4, the mouse was trained to be familiar with 
three exactly the same objects for 4 times. (C) On experimental Day 4, one of the 
three old subjects were replaced with a different new object to test their learning 
memory.  
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2.10.3 Barnes maze test 
 The protocol of the Barnes Maze test is adopted and modified from previous 
studies (Sunyer et al., 2007). The maze itself was made from a circular, 0.75-inch 
thick, white plastic board with a 48-inch diameter. Twenty holes with a diameter of 
2-inch were evenly spaced around the perimeter of the maze with a distance of 
1-inch to the edge (Figure 2.3). The maze was mounted on a rotating pedestal 
that was 30 inches above the ground and could rotate at its center. The escape 
cage was made from a black plastic box with a ramp connected beneath the 
escape hole for easy access. Four bright ceiling lamps and a noisy buzz were 
used as the aversive stimuli during the test. The maze and escape cage were 
thoroughly cleaned with 70% ethanol between testing sessions to avoid any 
olfactory cues and the maze was rotated randomly after every three mice to avoid 
intra-maze odor or visual cues.  
 During the test, the mice were habituated to the maze on day 1. Each time, 
one mouse was placed in the center of the maze, covered with an opaque 
cardboard chamber for 15 seconds then slowly guided to the escape hole with a 
3-liter glass beaker. Three minutes were given to the mouse to enter the escape 
hole on its own, if not, the mouse was nudged gently into the hole or placed 
directly into the hole. Afterward, the mouse was allowed to stay in the escape hole 
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for 2 minutes. The ceiling lights and white noise remained on while the mouse 
was exploring the maze and turned off immediately after they entered the escape 
hole. This procedure was repeated in all mice. On days 2-5, the mice were trained 
extensively to ensure a strong memory for the escape location (4 
times/mouse/day, 16 times in total) to learn to enter the escape hole by 
themselves. On these trials, the mice were allowed to stay in the escape cage for 
1 minute in each training trial. Memory retention was probed 2 days later on day 7. 
On probe session (day 7), the escape hole was covered and the spatial memory 
in the subject mice were tested. All behavior videos were captured by a Logitech 
c920 webcam. The primary latency, total latency, correct/error nose pokes, 
duration of stays in each quadrant and trace of locomotion were scored by 
experienced observers or the animal tracing program idTracker 2.1 blindly to the 
animals’ identity.  
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Figure 2.3 The Barnes maze used for mice spatial memory test. 
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Figure 2.3 The Barnes maze used for mice spatial memory test. The diameter 
of the maze is 48 inches wide while each of the escape hole is 2 inches in 
diameter. The target hole has an escaping tunnel underneath the maze for the 
mouse to escape and hide from the bright light. The mouse subject was placed in 
the middle of the maze in the beginning of the test and were allowed to run and 
explore freely on the maze throughout the test while the aversive stimuli, buzz and 
bright white light, are both turned on. The buzz and bright white light were both 
turned off immediately after the mouse entered the escape hole.  
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2.10.4 Animal use 
 All the procedures involving animal use were in compliance with the policies 
of the Institutional Animal Care and Use Committee (IACUC) at Boston University. 
C57BL/6J wild-type (#000664) and SIRT2 knock-out mice 
(B6.129-Sirt2tm1.1Fwa/J, #012772) were obtained from Jackson Laboratory (Bar 
Harbor, ME). Mouse colonies were maintained in the Laboratory Animal Care 
Facility (LACF) at Boston University, Charles River Campus. The mice aged 8-15 
weeks of either sex were randomly selected from different litters. Only mice with 
normal body size, morphology and no observable disabilities were used for the 
experiments.  
2.11 Data analysis and statistics 
All values are presented as mean ± S.E. Statistical analysis was performed 
using the student’s two-tailed t test to compare two groups, or analysis of variance 
(ANOVA) with Tukey post-hoc test for multiple groups. The highest and lowest 
values of each experimental group were excluded from the statistical analysis. P < 
0.05 is considered as statistically significant. P values are presented as P > 0.05 
(NS, not significant), ＊P < 0.05, ＊＊P < 0.01, ＊＊＊P < 0.001. 
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CHAPTER THREE 
SIRT2 regulates AMPAR acetylation in synaptic plasticity and memory 
formation 
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3.1 Abstract 
Sirtuins, the NAD
+
-dependent protein deacetylases, are well known for their 
positive roles in longevity, metabolism and overall health (Finkel et al., 2009; 
Haigis and Sinclair, 2010). Recently, sirtuins have been shown to be involved in 
neuronal regulation and higher brain functions (Gao J, 2010; Michan et al., 2010). 
However, the underlying mechanisms remain unclear. The AMPARs mediate the 
majority of fast excitatory synaptic transmission in the brain; alterations in AMPAR 
synaptic accumulation via post-translational modifications, turnover and trafficking 
serve as a primary mechanism for synaptic modification, plasticity, and learning 
and memory (Collingridge et al., 2004; Malinow and Malenka, 2002; Palmer et al., 
2005; Sheng and Hyoung Lee, 2003; Shepherd and Huganir, 2007). Here we 
report that AMPARs are subject to modulation by direct acetylation. Sirtuin 2 
(SIRT2), the brain-enriched and the sole cytosolically localized sirtuin family 
member, is the deacetylase regulating acetylation status and protein proteostasis 
of AMPARs via coordinating with the receptor ubiquitination. SIRT2 
overexpression causes a decrease in GluA1 acetylation and protein levels, 
whereas inhibition or deletion of SIRT2 results in an increase in GluA1 acetylation, 
accompanied by corresponding changes in receptor accumulation, trafficking and 
synaptic activity. SIRT2 knockout mice (Sirt2-/-) show marked up-regulation in 
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AMPAR acetylation and protein accumulation, and importantly, aberrant synaptic 
plasticity including LTP and LTD. Consistent with this, impairments in contextual 
and spatial memories of Sirt2-/- mice were observed in behavioral assays 
including fear conditioning, novel object recognition and the Barnes maze tests. 
These findings establish lysine acetylation as a novel PTM for AMPARs, which, 
via the dynamic control by SIRT2, regulates AMPAR proteostasis, trafficking and 
thus synaptic and brain cognitive functions.  
3.2. Introduction 
Sirtuins are a family of highly conserved NAD+-dependent protein 
deacetylases from yeast to mammals. Sirtuins are best known for their 
involvement in longevity (Haigis and Guarente, 2006; Kaeberlein et al., 1999; 
Kanfi et al., 2012). They are involved in a broad range of physiological processes 
such as energy metabolism, DNA repair and gene transcription (Longo and 
Kennedy, 2006; Michan and Sinclair, 2007). As protein deacetylases, sirtuins 
primarily target and deacetylate the lysine residues on histones to regulate the 
structure of chromatin which directly impacts the efficacy of gene transcription 
(Chuang et al., 2009). However, in recent years, more non-histone proteins have 
been identified as the targets of sirtuins, on which the deacetylation modification 
significantly affects their physiological functions (Brunet et al., 2004; Min et al., 
71 
 
2010; North et al., 2003; Yeung et al., 2004).  
Among the seven members of sirtuins (SIRT1-7), SIRT1 and SIRT2 have 
been shown largely associated with several nervous system disorders including 
AD, PD, dementia and amyotrophic lateral sclerosis (ALS) (Harting and Knoll, 
2010; Kim et al., 2007; Michan and Sinclair, 2007; Min et al., 2010; Outeiro et al., 
2007). In addition, SIRT1 and SIRT2 were recently identified as in the molecular 
pathways of memory formation (Gao J, 2010) and cocaine addiction (Renthal et 
al., 2009), which suggests, upon their broad involvements in nervous system 
diseases, they may possess more potential regulatory roles in synaptic plasticity 
and basic brain functions.  
The normal brain functioning is based on strictly controlled signal 
transmission between pre- and post-synaptic terminals. Excitatory synaptic 
transmission is particularly important for cognitive functions. In the brain, the 
majority of excitatory synaptic transmission in vertebrate central nervous system 
is mediated by glutamatergic receptors which directly influence the synaptic 
plasticity and cognition (Esteban, 2003; Frenguelli, 2013; Malinow and Malenka, 
2002; Nakanishi, 1994; Roche et al., 1994). Glutamatergic receptors are 
ligand-gated ion channels using glutamate as the neurotransmitter to transmit 
excitatory signals in brain. Among the three subtypes, AMPAR conveys most of 
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the fast synaptic transmission, which has been considered as the substrate of 
synaptic plasticity including Hebbian-type plasticity (LTP or LTD) and homeostatic 
plasticity (Malenka and Bear, 2004; Shepherd and Huganir, 2007; Wang et al., 
2012). Therefore, maintaining AMPARs at the right physiological status is crucial 
for normal brain/cognitive funtions. Aberrant regulation of AMPAR functions or 
dynamics in the brain are directly associated with cognitive impairments like 
Alzheimer’s disease or dementia (Chang et al., 2006). Post-translational 
modifications of the receptor protein, such as phosphorylation, ubiquitination and 
palmitoylation, are important biochemical processes that regulate the functions 
and intracellular dynamics of AMPARs (Lu and Roche, 2011). Previous studies 
showed that phosphorylation on the C-terminus of GluA1 subunit is essential for 
the formation of LTP and learning memory (Lee et al., 2003; Man et al., 2007), 
while palmitoylation of AMPARs controls their trafficking from Golgi apparatus to 
cell surface (Hayashi et al., 2005). Ubiquitination governs the proteolysis of 
AMPARs via ubiquitin-proteasome system that directly affects their intracellular 
stability (Lin et al., 2011; Lussier et al., 2011; Schwarz et al., 2010).  
We investigated the potential regulatory roles of sirtuins on AMPARs and their 
downstream effect on cognition. We found SIRT2, but not SIRT1 or 3, physically 
interacts with AMPAR via the lysine residues on its GluA1 subunit. It implies that 
73 
 
GluA1 is a substrate of protein deacetylation catalyzed by SIRT2. Indeed, we 
found GluA1 is subject to acetylation modification and the acetylation levels varied 
in different brain regions as well as in different developmental stages of the brain. 
Knocking-down SIRT2 expression by siRNA, or inhibiting SIRT2 catalytic function 
enhances GluA1 acetylation and protein level via the interaction with UPS system. 
In addition, we also found that p300 is the acetyltransferase that catalyzes GluA1 
acetylation. p300 physically interacts with AMPAR GluA1 subunit and activation of 
p300 mimicked effects after inhibition of SIRT2. In SIRT2 knock-out mice (Sirt2-/-), 
AMPAR exhibits high acetylation and elevated protein level. The synaptic 
plasticity (LTP and LTD), fear conditioning memory, and spatial and learning 
memories of Sirt2-/- mice were all found dramatically impaired.  
3.3 RESULTS 
3.3.1 SIRT2 interacts with GluA1 C-terminus via the lysine residues 
 As the only two sirtuins present in the cytosolic space of cells (Haigis and 
Sinclair, 2010; Michan and Sinclair, 2007), co-immunostaining of SIRT1 or SIRT2 
with AMPARs revealed their co-localization in cultured hippocampal neurons 
(Figure 3.1A, B, D). Consistent with previous studies, SIRT3 showed typical 
mitochondria-patterned localization (Figure 3.1C). Co-localization is a sign of the 
physical interaction between two proteins. To verify if there is a direct interaction 
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between SIRT1 or SIRT2 with AMPARs, we performed co-immunoprecipitation 
assay in human embryonic kidney (HEK) 293T cells. We found despite the 
co-localization of other sirtuins with AMPARs, only SIRT2 co-precipitated the 
GluA1 subunit of AMPARs (Figure 3.2A). To further verify this finding, we showed 
that endogenous AMPAR (GluA1) co-IPs SIRT2 from the whole brain lysate 
(Figure 3.2B). Additionally, GST-tagged GluA1 C-terminus (R1C-GST) 
precipitates SIRT2 from rat whole brain lysate as well (Figure 3.2C).  
 While being trafficked in the cell or inserted onto the cell membrane, all 
subunits composing AMPARs were enclosed in the small vesicles to form protein 
trafficking cargos (Shepherd and Huganir, 2007). Only the C-termini of the 
subunits are accessible for the enzymes in the cytoplasm and subject to different 
biochemical modifications (e.g. phosphorylation) (Lu and Roche, 2012a) (Figure 
3.3). Therefore, the majority of the proteins interacting with AMPAR attach to the 
C-termini of the subunits. As SIRT2 is a protein deacetylase, targeting primarily 
lysine residues, we thus generated a GluA1 subunit mutant (GluA1-4KR) with all 
four lysines mutated on the C-terminus. Using this mutant, we performed two-way 
co-IP assays between GluA1 and SIRT2 in HEK 293T cells. We found that the 
interaction between GluA1 and SIRT2 was severely interrupted (Figure 3.2D, E). 
This result indicates that SIRT2 interacts with GluA1 C-terminus via lysine 
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residues and that GluA1 may serve as a previously unknown substrate of SIRT2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
Figure 3.1 Sirtuins co-localize with AMPARs in cultured hippocampal 
neurons. 
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Figure 3.1 Sirtuins co-localize with AMPARs in cultured hippocampal 
neurons. (A) Co-immunostaining of endogenous GluA1 subunit (red) and SIRT1 
(green). (B) Co-staining of GluA1 (green) and SIRT2 (red). (C) Co-staining of 
GluA1 (red) and SIRT3 (green). (D) Quantification of co-localization rate shows 
that SIRT2 has highest co-localization rate with GluA1 in cultured hippocampal 
neurons. Bar graphs represent mean ± S.E., ＊P < 0.05. One-way ANOVA with 
Tukey post-hoc test. 
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Figure 3.2 SIRT2 interacts with AMPAR in vitro and in vivo, via the lysine 
residues on the C-terminus of GluA1 subunit. 
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Figure 3.2 SIRT2 interacts with AMPAR in vitro and in vivo, via the lysine 
residues on the C-terminus of GluA1 subunit. (A) In HEK 293T cells, SIRT2, 
but not SIRT1 or 3, co-IPs the GluA1 subunit of AMPAR. (B) Endogenous GluA1 
co-IPs SIRT2 in whole brain lysis. (C) GST-tagged R1 C-terminus pulls down 
SIRT2 from whole brain lysis. (D, E) The interaction between AMPAR and SIRT2 
is partially dependent on the lysine residues on the C-terminus of GluA1. WCL: 
whole cell lysate.  
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
Figure 3.3 The structure of GluA1 and the amino acids sequence of GluA1 
C-terminus. 
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Figure 3.3 The structure of GluA1 and the amino acids sequence of GluA1 
C-terminus. The structure of the GluA1 subunit of AMPAR shows two N-terminus 
domains (NTD), four transmembrane domains (TMD) and a C-terminus domain 
(CTD). Four lysine residues located on the C-terminus of GluA1 (K831, K837, 
K840 and K886). The amino acids sequence is shown in the lower panel.  
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3.3.2 SIRT2 deacetylates AMPARs in neurons 
 As SIRT2 is a protein deacetylase, its physical interaction with GluA1 made 
us speculate whether GluA1 is subject to modification by lysine acetylation. To 
verify that, we first did in vivo protein acetylation assay of GluA1. GluA1 protein 
was immunoprecipitated (IP) from brain tissue lysis from different regions: 
prefrontal cortex (PFC), hippocampus (Hippo) and cerebellum (Cere). We found 
that the endogenous GluA1 is indeed subject to acetylation modification and the 
strengths vary in different regions: highest in hippocampus while lowest in 
cerebellum (Figure 3.4A). As is shown in Figure 3.4A, the SIRT2 levels in different 
brain regions negatively correlate with GluA1 acetylation levels, implicating a 
negatively correlated relationship between SIRT2 to GluA1 acetylation.  
 We also examined the GluA1 acetylation at different developmental stages of 
the brain. We found that GluA1 acetylation is higher in the embryonic PFC 
compared to adult PFC, while correspondingly, SIRT2 level is higher in adult 
compared to embryos (Figure 3.4B). This is also consistent with previous study 
that SIRT2 increases during the maturation of the brain (Maxwell et al., 2011). To 
determine if it is indeed that SIRT2 expression level affecting GluA1 acetylation, 
we used siRNA targeting on SIRT2 that significantly down-regulated SIRT2 
expression in 293T cells without affecting SIRT1 level (Figure 3.4C). Indeed we 
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found the acetylation level of recombinant GluA1 was dramatically up-regulated. 
In addition to recombinant GluA1, to verify SIRT2 effect to endogenous GluA1 
acetylation in neurons, we treated culture cortical neurons with specific SIRT2 
catalytic function inhibitor, B2 (20 μM) or AGK2 (30 μM), which both significantly 
enhanced endogenous GluA1 acetylation in neurons (Figure 3.4D, E). Meanwhile, 
overexpression of SIRT2 or mutation of the lysine residues on GluA1 C-terminus 
both dramatically decreased GluA1 acetylation level in 293T cells (Figure 3.5A, 
B).  
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Figure 3.4 SIRT2 deacetylates AMPAR both in vivo and in vitro. 
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Figure 3.4 SIRT2 deacetylates AMPAR both in vivo and in vitro. (A) GluA1 
subunit of AMPAR is subject to acetylation modification and the intensity of 
acetylation vary in different brain regions (PFC: prefrontal cortex; Hippo: 
hippocampus; Cere: cerebellum; Ace-K: acetylated lysine) of adult rat. (B) 
Acetylation level of GluA1 is lower in adult rat brain compared to embryos. 
AMPAR acetylation intensities of different brain regions or developmental stages 
negatively correlate with the SIRT2 protein levels (A, B). (C) Knock-down SIRT2 
expression by siRNA (siSIRT2) in HEK 293T cells significantly increases GluA1 
acetylation level. (D, E) Inhibition of SIRT2 catalytic function by B2 or AGK2 
significantly enhances GluA1 acetylation in cultured neurons (Ace-GluA1: 
acetylated GluA1 subunit). Bar graphs represent mean ± S.E., ＊P < 0.05. 
One-way ANOVA with Tukey post-hoc test (A) and Student’s two-tailed t test 
(B-E).  
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Figure 3.5 GluA1 acetylation is dependent on lysine residues and regulated 
by SIRT2 deacetylase. 
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Figure 3.5 GluA1 acetylation is dependent on lysine residues and regulated 
by SIRT2 deacetylase. (A) SIRT2 overexpression down-regulates GluA1 
acetylation in HEK 293T cells. (B) Mutation of all the lysine residues on GluA1 
C-terminus dramatically decreases GluA1 acetylation in HEK 293T cells. Bar 
graphs represent mean ± S.E., ＊P < 0.05. Student’s two-tailed t test.  
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3.3.3 Activity-dependent AMPAR acetylation 
 Activity level of the neural network directly influences the regulation and 
functions of AMPARs. Previous studies have shown the intensity of AMPAR PTM 
is directly associated with the neural activity (Lee et al., 2000; Lin et al., 2009; 
Widagdo et al., 2015b). For example, activation of neural network enhances, 
while silencing of neural activity decreases, AMPAR ubiquitination (Lussier et al., 
2011; Widagdo et al., 2015a). In our study, we also tested whether AMPAR 
acetylation is connected with neural activity level. Indeed, we found inhibition of 
neural activity by prolonged tetrodotoxin (TTX, 2 μM, 30min) or TTX with APV (50 
μM, 30min) both increase GluA1 acetylation (Figure 3.6A). Meanwhile, cultured 
cortical neurons treated by KCl (20 mM), AMPA (40 μM) or bicuculline (20 μM) for 
30min in ACSF, which enhances neural activity, down-regulates GluA1 acetylation 
(Figure 3.6B). Together these data suggest the acetylation level of AMPAR is in 
direct association with the activity level of the neural network.  
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Figure 3.6 Activity-dependent regulation of AMPAR acetylation. 
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Figure 3.6 Activity-dependent modulation of AMPAR acetylation. (A) 
Silencing of neural activity by TTX or TTX+APV for 30min in 1X ACSF 
dramatically increases GluA1 acetylation. (B) Activation of neural network by KCL, 
AMPA or bicuculline for 30min in 1X ACSF drastically decreases GluA1 
acetylation in culture cortical neurons. Bar graphs represent mean ± S.E., ＊P 
< 0.05, ＊＊P < 0.01. One-way ANOVA with Tukey post-hoc test.  
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3.3.4 Interactions amongst the PTMs of AMPARs 
 Several previous studies have also demonstrated that if a protein is subject to 
several post-translational modifications, these PTMs may interact with each other 
to either facilitate or suppress one another’s catalytic efficacy. For example, 
acetylation of tau inhibits its phosphorylation (Min et al., 2010) while 
phosphorylation of AMPK facilitates its acetylation (Lin et al., 2012). In addition, 
given targeting on lysines as well, acetylation is well known for competing with 
ubiquitination to regulate the intracellular protein stability (Caron et al., 2005). 
Therefore, we decided to determine whether the competition between acetylation 
and ubiquitination is also occurring on GluA1 C-terminus. In cultured cortical 
neurons, we observed a significant decrease of GluA1 acetylation (Figure 3.7A) 
when the GluA1 ubiquitination was enhanced by MG132 treatment (10 μM, 9hr). 
And vice versa, when the GluA1 acetylation has been increased by SIRT2 
inhibition with siRNA or B2 (20 μM), the ubiquitination of AMPAR is also 
suppressed (Figure 3.7B, C). More strikingly, the competitive relationship between 
GluA1 acetylation and ubiquitination was clearly observed in the in vitro 
developmental course of cultured cortical neurons. From DIV 5 to 19, the 
acetylation level of GluA1 continuously went down while its ubiquitination level 
kept going up (Figure 3.7D). In line with the AMPAR acetylation change, SIRT2 
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expression was gradually up-regulated over this time course as well (Figure 
3.7D).  
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Figure 3.7 Competition between AMPAR acetylation and ubiquitination. 
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Figure 3.7 Competition between AMPAR acetylation and ubiquitination. (A) 
Artificial enhancement of GluA1 ubiquitination by MG132 treatment 
down-regulates its acetylation. (B, C) Inhibition of SIRT2 function by B2 in cultured 
neurons (B) or expression by siRNA (C) in HEK 293T cells increases GluA1 
acetylation while decreases ubiquitination. (D) The competitive relationship 
between AMPAR acetylation and ubiquitination has been clearly observed in the 
in vitro developmental course of cultured cortical neurons from DIV 5 to DIV 19.  
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 In addition to the competition between GluA1 acetylation and ubiquitination, 
we also found interaction between its acetylation and phosphorylation. As is 
shown in Figure 3.8, in cultured cortical neurons, increase of GluA1 acetylation by 
B2 (SIRT2 inhibitor) overnight treatment significantly increased GluA1 
phosphorylation (Figure 3.8A). However, when we enhanced GluA1 
phosphorylation by 3-isobutyl-1-methylxanthine (IBMX) + Forskolin 1 hour 
treatment, there is no obvious change of GluA1 acetylation has been observed 
(Figure 3.8B). These data together showed GluA1 acetylation directly competes 
with ubiquitination and also facilitates the phosphorylation of GluA1 at S845. 
However, GluA1 phosphoryation on S845 itself has no obvious effect on GluA1 
acetylation.  
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Figure 3.8 The interaction between AMPAR phosphorylation and 
acetylation.  
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Figure 3.8 The interaction between AMPAR phosphorylation and acetylation. 
(A) Enhanced GluA1 acetylation by B2 overnight treatment leads to increased 
phosphorylation at S845. (B) In contrast, enhanced GluA1 phosphorylation at 
S845 site has no obvious effect on its acetylation. Bar graphs represent mean ± 
S.E., ＊P < 0.05. Student’s two-tailed t test.  
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3.3.5 SIRT2 regulates AMPAR expression in cultured hippocampal neurons.  
Maintaining normal intracellular dynamics of AMPARs is crucial to normal 
synaptic transmission, plasticity and even cognitive functions (Shepherd and 
Huganir, 2007). Previous studies showed lysine acetylation directly associates 
with the intracellular stability of its target substrates (Glozak et al., 2005; Inuzuka 
et al., 2012). High acetylation level directly associates with high protein stability in 
cells. Therefore, we questioned whether SIRT2 regulates the protein expression 
and stability of AMPARs in neurons. We first overexpressed SIRT1, 2, 3 
recombinant proteins in cultured hippocampal neurons for 72 hours and found 
SIRT2, but not SIRT1 or SIRT3, dramatically down-regulated AMPAR expression 
level in neurons (Figure 3.9A, B). The same phenomenon has been observed in 
HEK 293T cells when we co-expressed GluA1-GFP with SIRT1, 2, 3 for 48 hours. 
Only SIRT2 significantly decreased GluA1-GFP level in 293T cells (66.7 ± 10.2%, 
n = 3, P < 0.05, Figure 3.9C, D). Consistent with this, when we inhibit the catalytic 
function of SIRT2 in cultured cortical neurons by B2 (20 μM for 24 hours), or to 
knock down SIRT2 expression by siRNA (siSIRT2) in 293T cells, it significantly 
enhances the expression level of GluA1-GFP (Figure 3.10A, B).  
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Figure 3.9 SIRT2, but not SIRT1 or 3, downregulates AMPAR expression in 
cultured hippocampal neurons.  
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Figure 3.9 SIRT2, but not SIRT1 or 3, downregulates AMPAR expression in 
cultured hippocampal neurons. (A, B) Plasmids carrying the cDNA of SIRT1, 2, 
3 and EGFP were co-transfected into 2-w cultured hippocampal neurons to 
express the target proteins for 72 hours. Immunostaining of the endogenous 
GluA1 subunit of AMPAR was performed afterward. The overexpression SIRT2, 
but not SIRT1 or 3 dramatically down-regulates the expression of AMPAR (red). 
(C, D) GluA1-GFP plasmid was co-transfected with SIRT1, 2, 3 plasmids 
respectively into HEK 293T cells and incubated for 48 hours before western 
blotting protein analysis. Similar as in the cultured neurons, only SIRT2 
overexpression, but not SIRT1 or 3, down-regulates GluA1-GFP expression level. 
Bar graphs represent mean ± S.E., ＊＊＊P < 0.001, ＊＊P < 0.01. One-way 
ANOVA with Tukey post-hoc test.  
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Figure 3.10 SIRT2 effects on AMPAR are abolished by the GluA1-4KR 
mutant.  
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Figure 3.10 SIRT2 effects on AMPAR are abolished by the GluA1-4KR 
mutant. (A) In cultured cortical neurons, inhibition of SIRT2 activity by B2 
overnight treatment increases AMPAR expression. (B) Knock-down SIRT2 
expression by siRNA (siSIRT2) in HEK 293T cells significantly increases 
GluA1-GFP expression. Bar graphs represent mean ±  S.E., ＊P < 0.05. 
Student’s two-tailed t test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
3.3.6 Acetylation influences AMPAR expression and trafficking in neuron via 
interaction with ubiquitination 
 Acetylation is well known for regulating intracellular protein stability via its 
interaction with ubiquitin-proteasome system (Sadoul et al., 2008). Acetylation 
and ubiquitination often compete with each other as they could target on the same 
lysine residues of the substrate proteins (Yang and Seto, 2008). Once the acetyl 
groups occupy the lysine residues of a peptide, they prevent the ubiquitins from 
binding to the lysines, which further prevents the recognition of this peptide by the 
proteolysis machinery such as proteasomes (Ciechanover and Brundin, 2003). 
Therefore, we determined whether the SIRT2-induced AMPAR down-regulation is 
mediated by the UPS system. We utilized the GluA1-4KR mutant again that 
abolishes the GluA1 ubiquitination (Lin et al., 2011). If SIRT2 decreases AMPAR 
expression through enhanced ubiquitination, it should have no effect on 
GluA1-4KR mutant. As is shown in Figure 3.11A, indeed we observed that 
GluA1-4KR mutant completely abolished SIRT2 effect and restored GluA1 level 
back to the same level as GluA1-WT, while SIRT2 itself significantly decreases 
GluA1-WT expression (Figure 3.11A). As a direct evidence, we found that 
overexpression of SIRT2 leads to enhanced GluA1 ubiquitination (Figure 3.11B). 
Additionally, to verify that AMPAR ubiquitination indeed lies downstream of SIRT2, 
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we employed an ubiquitin mutant with lysine 63 residue mutated to an arginine 
(UbiK63R), which specifically abolish GluA1 ubiquitination. Like the GluA1-4KR 
mutant, co-expression of UbiK63R rescues SIRT2-induced AMPAR decrease as 
well (Figure 3.11D). All these data together showed that SIRT2 regulates GluA1 
expression via the interaction between GluA1 acetylation and ubiquitination.  
3.3.7 AMPAR acetylation influences its intracellular stability 
To verify whether the AMPAR acetylation affects its intracellular stability and 
trafficking, we performed cycloheximide (CHX, 100 μM) tracing experiment to test 
the receptor protein degradation rate. With the presence of SIRT2, which 
indicates lower AMPAR acetylation level, the degradation rate of GluA1 is 
significantly faster compared to the pcDNA control (Figure 3.12A). In addition, as 
was shown previously, we noticed that the AMPAR acetylation level is at its 
highest at DIV 7 while the lowest at DIV 14 (Figure 3.7D). Consistent with this, we 
observed that the AMPAR at DIV 14 degrades significantly faster than at DIV7 
(Figure 3.12B). These data demonstrate the acetylation level of AMPAR directly 
influences its intracellular stability.  
 To determine whether AMPAR acetylation affects its intracellular trafficking, 
we also performed receptor internalization assay to assess the internalization 
rates of AMPAR under different acetylation conditions. Inhibition of SIRT2 function 
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by B2 (20 μM for 24 hours) significantly decreased AMPA-induced (100 μM for 1 
minute) (Beattie et al., 2000) AMPAR internalization (Figure 3.12C, D), indicating 
enhanced stability of AMPAR on the cell membrane. 
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Figure 3.11 SIRT2 controls AMPAR expression via interaction with the 
receptor ubiquitination 
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Figure 3.11 SIRT2 controls AMPAR expression via interaction with the 
receptor ubiquitination. (A) The 4KR mutation abolishes SIRT2-induced 
AMPAR down-regulation. (B) SIRT2 overexpression enhance AMPAR 
ubiquitination. (C) Ubiquitin K63R mutant abolishes SIRT2-induced AMPAR 
over-ubiquitination. (D) Co-expression of ubiquitin K63R mutant rescues 
SIRT2-induced AMPAR down-regulation. Bar graphs represent mean ± S.E., ＊
P < 0.05. One-way ANOVA with Tukey post-hoc test. 
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Figure 3.12 Receptor protein degradation assay and internalization assay of 
AMPAR under different acetylation status.  
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Figure 3.12 Receptor protein degradation assay and internalization assay of 
AMPAR under different acetylation status. (A) With the presence of SIRT2, the 
degradation rate of GluA1 in HEK 293T cells has been dramatically enhanced 
compared to the pcDNA control. (B) With a lower acetylation level at DIV 14, 
AMPAR degrades faster compared to at DIV 7 in cultured cortical neurons. (C, D) 
Enhanced acetylation by B2 24-hr treatment slows down its internalization rate. 
Bar graphs represent mean ± S.E., ＊P < 0.05. Student’s two-tailed t test.  
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3.3.8 SIRT2 regulates AMPAR expression and miniature synaptic 
transmission in neurons 
To look into the potential functional impacts that SIRT2 may produce on 
AMPAR-mediated transmission, we first investigated whether SIRT2 changes the 
functional AMPAR level at synapses and surface of neurons. Synaptic GluA1 
immunostaining and surface protein biotinylation assay showed indeed, 24-hour 
inhibition of SIRT2 catalytic function B2, significantly enhanced both synaptic and 
surface AMPAR level (Figure 3.13A). We also performed patch-clamping 
recording to monitor the miniature synaptic transmission through glutamatergic 
synapses, which are primarily mediated by AMPARs. We did observe 24-hour B2 
treatment enhanced the amplitudes of miniature synaptic transmission current 
from 11.49 ± 1.58 pA to 16.02 ± 1.44 pA (139.4 ± 9.0%, n = 12 cells, P < 0.05, 
Figure 3.13B) while without altering the frequency (n = 12 cells, P > 0.05, data not 
shown). These data together showed that SIRT2 does affect AMPAR protein 
expression in neurons as well as the AMPAR-mediated synaptic transmission.  
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Figure 3.13 SIRT2 regulates synaptic AMPAR expression and miniature 
transmission.  
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Figure 3.13 SIRT2 regulates synaptic AMPAR expression and miniature 
transmission. (A) Inhibition of SIRT2 function by B2 treatment (20 μM, 24-hr) 
increases synaptic AMPAR expression. The synaptic AMPAR is indicated by the 
GluA1 subunit staining (red). Only red puncta co-localized with PSD95 (green) 
were quantified. (B) B2 treatment increases AMPAR-mediated synaptic miniature 
transmission, shown by patch-clamping recording in cultured hippocampal 
neurons. This experiment was performed by collaborator James Gilbert from 
Biology department of Boston University. Bar graphs represent mean ± S.E., ＊
＊＊P < 0.001, ＊P < 0.05. Student’s two-tailed t test. 
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3.3.9 p300/CBP is an acetyltransferase of AMPA receptor 
 As we established SIRT2 as the deacetylase, we also wondered which HAT 
may be the acetyltransferase of AMPARs. We chose four well studied HATs as our 
candidates: p300/CBP-associated factor (PCAF), p300, CBP and GCN5 for the 
preliminary screening by GluA1 in vitro acetylation assay. Detailed procedures of 
the assay is described in the Methods (Chapter 2). As is shown in Figure 3.14A, 
only p300/CBP produces significantly stronger acetylation signal compared to the 
control, on GluA1C-GST protein. To support this result, the chemical inhibitor of 
p300, c646 (40 μM) significantly down-regulates the GluA1 acetylation in culture 
cortical neurons (Figure 3.14B). Consistent with our previous finding, 
co-expression with p300 results in significantly higher GluA1 expression in HEK 
293T cells (Figure 3.15A, B) while the effect is mostly abolished by GluA1-4KR 
mutant (Figure 3.15B), indicating the crucial roles of lysine residues in 
p300-mediated GluA1 up-regulation. Consistent with the AMPAR protein changes, 
the miniature synaptic transmission has been dramatically down-regulated after 
the p300 inhibitor (C646) treatment (Figure 3.15C).  
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Figure 3.14 p300/CBP is the acetyltransferase of AMPAR.  
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Figure 3.14 p300/CBP is the acetyltransferase of AMPAR. (A) In vitro 
acetylation assay shows p300/CBP, but not the other HATs, acetylates the 
GluA1-C terminus. (B) Inhibition of p300/CBP function by C646 decreases 
endogenous GluA1 acetylation in cultured cortical neurons.  
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Figure 3.15 p300 up-regulates AMPAR expression and miniature synaptic 
transmission.  
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Figure 3.15 p300 up-regulates AMPAR expression and miniature synaptic 
transmission. (A) Co-expression with p300, but not PCAF, up-regulates GluA1 
expression in HEK 293T cells. (B) GluA1-4KR mutant abolishes p300-induced 
GluA1-WT up-regulation, indicating the lysines-dependence of p300 effect. (C) 
Chemical p300 inhibitor, C646, decreases AMPAR-mediated miniature synaptic 
transmission in cultured cortical neurons. This experiment was performed by 
collaborator James Gilbert from Biology department of Boston University. Bar 
graphs represent mean ± S.E., ＊P < 0.05. Student’s two-tailed t test. 
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3.3.10 Normal acetylation of AMPA receptor is essential for synaptic 
plasticity and learning memory 
To further investigate the role of SIRT2 on AMPARs and neural function in 
vivo, we utilized SIRT2 knock-out mice (Sirt2-/-). The transgenic mice showed 
normal body weight and gross brain anatomy (Figure 3.16A, B), with no 
measurable differences in hippocampal structure or volume (Figure 3.16C), or 
spine size and density (Figure 3.16D). However, in line with findings in cultured 
neurons, Sirt2-/- mice demonstrated a marked increase of AMPAR acetylation and 
receptor amounts. In comparison, no obvious changes were found in other 
synaptic proteins including GluN1 and PSD-95 in the transgenic mice (Figure 
3.17).  
 Because AMPAR expression and trafficking are crucial for synaptic plasticity, 
we next examined LTP and LTD in hippocampal slices from Sirt2-/- mice. Lack of 
SIRT2 did not cause changes in synaptic properties with regards to the paired 
pulse facilitation and input/output function (Figure 3.18A, B), relative to the 
wild-type control mice. However, both LTP and LTD were significantly impaired in 
Sirt2-/- mice (Figure 3.18C, D). Given the role of hippocampal synaptic plasticity in 
learning and memory (Collingridge et al., 2010; Shepherd and Huganir, 2007), we 
then performed several behavioral assays in Sirt2-/- mice including fear 
119 
 
conditioning, spatial learning, and novel object discrimination tests (Figure 
3.19-22). In fear conditioning tests, the Sirt2
-/-
 mice showed significantly impaired 
contextual fear memory (Figure 3.19A, B, 3.20B), a function mainly dependent on 
the hippocampus (McEchron et al., 1998). However, tone-associated fear memory, 
which is amygdala-dependent, remained intact, suggesting that learning-related 
synaptic plasticity deficits may be more extensive in the hippocampus (Figure 
3.19C, D). In contrast, the basal locomotion or shock sensitivity did not differ 
between Sirt2-/- and WT mice (Figure 3.19E). In novel object discrimination tests 
(Figure 3.21), we found that the Sirt2-/- mice were significantly slower in learning 
during the training sessions (Figure 3.21A), whereas their basal exploration of the 
objects showed no difference (Figure 3.21C). In probe sessions, Sirt2-/- mice 
showed impaired memory to the old objects (Figure 3.21B). Finally, we employed 
the Barnes maze test to assess spatial memory. Sirt2-/- mice seemed to be normal 
in locating the target escape hole across training sessions when compared to 
wildtype mice (Figure 3.22E, F). However, in Sirt2-/- mice, we observed 
significantly reduced accuracy and prolonged latency in finding the target hole 
(Figure 3.22A, B), as well as reduced exploration time in the target quadrant 
(Figure 3.22C, D). These findings strongly indicate impairments in long-term 
memory in SIRT2-lacking mice. 
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Figure 3.16 SIRT2 knock-out mice (Sirt2-/-) do not exhibit significant gross 
anatomical differences compared to the wildtype mice.  
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Figure 3.16 SIRT2 knock-out mice (Sirt2-/-) do not exhibit significant gross 
anatomical differences compared to the wildtype mice. (A) Sirt2
-/-
 mice have 
similar body size and fur color compared to wildtype C57BL//6J mice. No obvious 
developmental deficits are observed in Sirt2-/- mice. (B) The gross size and 
anatomy of Sirt2-/- mice brain is similar to the wildtype mice. (C) There no obvious 
developmental deficits are observed in terms of hippocampus size or structure in 
Sirt2-/- mice. (D) The spine sizes and densities are comparable to each other in 
wildtype and Sirt2-/- mice. Bar graphs represent mean ± S.E., NS, not significant. 
Student’s two-tailed t test. 
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Figure 3.17 Western blot analysis of different protein levels between 
wildtype and Sirt2
-/- 
C57BL/6J mice.  
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Figure 3.17. Western blot analysis of different protein levels between 
wildtype and Sirt2
-/- 
C57BL/6J mice. The total protein and acetylation levels of 
AMPAR (GluA1 subunit) in hippocampi show similar increases in Sirt2-/- mice 
compared to the wildtype mice, while some other synaptic proteins like PSD-95, 
GluN1 or CaMKIIα do not show obvious changes. The internal control protein 
GAPDH indicates even loading of samples. Bar graphs represent mean ± S.E., 
＊＊＊P < 0.001, NS, not significant. Student’s two-tailed t test. 
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Figure 3.18 The synaptic plasticity (LTP/LTD) is impaired in Sirt2-/- mice 
compared to wildtypes.  
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Figure 3.18 The synaptic plasticity (LTP/LTD) is impaired in Sirt2-/- mice 
compared to wildtypes. (A, B) There is no significant difference between WT 
and SIRT2 KO mice in synaptic paired pulse facilitation (A) and input/output curve 
(B). (C, D) Recordings in hippocampal CA1 regions of acute brain slices showed 
impairments in LTP (C) and LTD (D) in Sirt2-/- mice (n = 10-12). Bar graphs 
represent mean ± S.E., ＊P < 0.05, ＊＊P < 0.01. Student’s two-tailed t test. This 
experiment was performed by collaborator Dr. Shaomin Li from Brigham and 
Woman’s hospital, Harvard Medical School.  
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Figure 3.19 Sirt2-/- mice show impaired contextual fear memory.  
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Figure 3.19 Sirt2-/- mice show impaired contextual fear memory. (A, B) The 
contextual fear memory of Sirt2
-/-
 mice is significantly impaired compared to the 
wildtypes. (C, D) The tone-dependent fear memory remains intact in Sirt2-/- mice, 
comparing with the wildtypes. (E) No change was observed in the sensitivities to 
electrical shock (ES) between Sirt2-/- mice and wildtypes. (F) Low expression of 
endogenous SIRT2 in amygdala of wildtype C57BL/6J mice brains. Bar graphs 
represent mean ± S.E., ＊P < 0.05, ＊＊P < 0.01, ＊＊＊P < 0.001, NS, not 
significant. Student’s two-tailed t test. 
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Figure 3.20 Representative locomotion histograms of WT and Sirt2-/- mice in 
the fear conditioning tests.
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Figure 3.20 Representative locomotion histograms of WT and Sirt2-/- mice in 
the fear conditioning tests. (A) Day 1, fear conditioning training. The WT and 
Sirt2-/- mice showed similar locomotion patterns during basal conditions and after 
ES (electrical shock). (B) Day 2, Examination of contextual fear memory. Sirt2-/- 
mice showed much reduced freezing than the WT mice. (C) Day 3, Examination 
of tone fear memory. The WT and Sirt2-/- mice showed similar patterns of 
locomotion (first 3 min) and freezing responses (last 2 min) to the tone. 
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Figure 3.21 Sirt2-/- mice show impaired learning memory to novel objects.  
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Figure 3.21 Sirt2-/- mice show impaired learning memory to novel objects. (A) 
During the training phase, the Sirt2
-/-
 mice show significantly lower learning 
capability to the old objects than the wildtype mice. (B) In the probing session, the 
Sirt2-/- mice show dramatically lower capability to retrieve the learning memory to 
the novel objects, comparing to the wildtype mice. (C) During the first round of 
training, the Sirt2-/- and wildtype mice show similar level of curiosity to the test 
objects, indicating their similar basal activities in the test arena. Bar graphs 
represent mean ± S.E., ＊P < 0.05, ＊＊P < 0.01, ＊＊＊P < 0.001, NS, not 
significant. Student’s two-tailed t test. 
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Figure 3.22 Barnes maze test shows impaired spatial memory of the Sirt2-/- 
mice.  
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Figure 3.22 Barnes maze test shows impaired spatial memory of the Sirt2-/- 
mice. The Barnes maze test revealed the spatial memory impairment in Sirt2
-/-
 
mice. The numbers of nose pokes to the target hole, or the adjacent holes 
(L+Target+R) were reduced significantly in Sirt2-/- mice (A). Sirt2-/- mice took 
longer time to reach the target hole (B), and spent less time in the target quadrant 
(C), as was shown in the representative path tracing (D). T, target; L, left; O, 
opposite; R, right. Bar graphs represent mean ± S.E., ＊P < 0.05, ＊＊P < 0.01, 
＊＊＊P < 0.001, NS, not significant. Student’s two-tailed t test. 
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3.4 Discussion 
 My study for the first time demonstrates that AMPARs are subject to lysine 
acetylation as a novel PTM. Acetylation has been considered a modification 
mainly for nuclear histone proteins, although recently a few other cytosolic 
proteins including tubulin, AMP-activated protein kinase (AMPK) and tau have 
also been shown to be substrates (Lu et al., 2011; Min et al., 2010; North et al., 
2003). We find that GluA1 subunits have high levels of acetylation under basal 
conditions, which can be efficiently regulated by SIRT2. Through competition for 
the lysine sites at the GluA1 C-terminus, acetylation and ubiquitination of 
AMPARs reach a balance in order to maintain receptor proteostasis (Caron et al., 
2005). Deacetylation of AMPARs by the brain-enriched SIRT2 facilitates receptor 
ubiquitination, leading to receptor internalization and proteasomal degradation 
(Figure 5.1). Therefore, alterations in SIRT2 expression and/or its enzymatic 
activities may be of crucial importance for AMPAR turnover, synaptic plasticity and 
cognitive brain function. 
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CHAPTER FOUR 
Resveratrol up-regulates AMPA receptor expression via AMP-activated protein 
kinase – mediated protein translation 
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4.1 Abstract 
Resveratrol is a phytoalexin that confers overall health benefits including positive 
regulation in brain function such as learning and cognition. However, whether and how 
resveratrol affects synaptic activity remains largely unknown. AMPARs are 
glutamatergic receptors that mediate the majority of fast excitatory transmission and 
synaptic plasticity, and thus play a critical role in higher brain functions, including 
learning and memory. We find that in rat primary neurons, resveratrol can rapidly 
increase AMPAR protein level, AMPAR synaptic accumulation and the strength of 
excitatory synaptic transmission. The resveratrol effect on AMPAR protein expression 
is independent of sirtuin 1 (SIRT1), the conventional downstream target of resveratrol, 
but rather is mediated by AMPK and subsequent downstream phosphoinositide 
3-kinase (PI3K)/Akt signaling. Application of the AMPK specific activator AICAR 
mimics the effects of resveratrol on both signaling and AMPAR expression. The 
resveratrol-induced increase in AMPAR expression results from elevated protein 
synthesis via regulation of the eukaryotic initiation factor (eIF) 4E/4G complex. 
Disruption of the translation initiation complex completely blocks 
resveratrol-dependent AMPAR up-regulation. These findings indicate that resveratrol 
may regulate brain function through facilitation of AMPAR biogenesis and synaptic 
transmission. 
 
4.2 Introduction 
Resveratrol is a phytoalexin presenting at high concentration in grapes and nuts, 
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which has been broadly used as a dietary supplement and shows beneficial effects on 
overall health (Chung et al., 2012; Kodali et al., 2015; Witte et al., 2014). Resveratrol 
protects neurons from cell death induced by different pathological conditions such as 
glutamate-induced excitotoxicity (Chung et al., 2011), oxidative stress (Fukui et al., 
2010), ischemia and epilepsy (Wu et al., 2009). Resveratrol can also ameliorate the 
symptoms associated with neurodegenerative diseases including AD (Vingtdeux et al., 
2008; Wang et al., 2008), PD (Jin et al., 2008) and HD (Parker et al., 2005; Sinclair, 
2005). 
Resveratrol stimulates sirtuins (SIRTs) activity, a NAD+-dependent protein 
deacetylases family (Howitz et al., 2003; Smith et al., 2009). There are seven 
members in sirtuin family (SIRT1-7). SIRT1 has been shown to be the primary target 
of resveratrol (Baur et al., 2006), which is also thought to underlie most of the 
beneficial effects associated with resveratrol (Baur and Sinclair, 2006). Additionally, 
resveratrol activates the metabolic regulator AMPK (Dasgupta and Milbrandt, 2007), 
the primary bioenergy sensor responsible for the maintenance of cellular energy 
homeostasis (Hardie, 2007). 
AMPARs are ligand-gated glutamatergic ion channels that mediate the majority of 
excitatory neurotransmission in the brain (Shepherd and Huganir, 2007). Alterations 
in AMPAR synaptic accumulation serve as the molecular mechanisms underlying the 
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expression of synaptic plasticity, including LTP/LTD and homeostatic synaptic 
plasticity (Malenka, 2003; Malinow, 2003; Pozo and Goda, 2010; Turrigiano, 2008). 
AMPAR abundance in the cell is determined by the balanced processes of protein 
translation and degradation (Lin et al., 2011; Zhang et al., 2009). Changes in AMPAR 
function and its dynamic trafficking have direct impacts on synaptic transmission and 
cognitive functions (Kessels and Malinow, 2009; Lee et al., 2003). Aberrant AMPAR 
function is also associated with the cognitive impairments related to multiple 
neurological diseases (Chang et al., 2006; Hsieh et al., 2006). However, whether 
resveratrol has a role in glutamate receptor expression and synaptic localization 
remains unknown. 
Here we report that resveratrol treatment induces an increase in AMPAR protein 
level and its synaptic localization, leading to an enhancement in the strength of 
synaptic transmission. The resveratrol effect on AMPAR requires the activity of AMPK 
and the downstream PI3K/Akt pathway, but is independent of SIRT1. Furthermore, 
we show that the resveratrol-induced increase in AMPAR level is not a consequence 
of suppressed protein degradation, rather, it results from stimulated protein synthesis 
mediated by the eIF4E/4G translation initiation complex. Consistent with the role of 
AMPK, the effect of resveratrol on AMPAR expression and signaling cascades can be 
reproduced by application of an AMPK-specific activator. These findings demonstrate 
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a novel effect for resveratrol on glutamate receptor regulation, a process that may 
underlie the cognitive benefits of resveratrol on brain function. 
4.3 Results 
4.3.1 Resveratrol rapidly increases AMPAR levels in neurons 
To investigate the potential effects of resveratrol on AMPARs, we incubated 2 
week-old cultured cortical neurons with varying concentrations of resveratrol (10 - 
40 μM) for 4 hours and evaluated AMPAR protein levels via western blot. We 
found that 4 hours of either 20 µM or 40 µM resveratrol treatment significantly 
increased the total amount of GluA1 subunits (Figure 4.1A). Based on this result, 
we used 40 μM as the working concentration of resveratrol for all subsequent 
experiments. We next investigated the temporal profile of resveratrol treatment on 
AMPAR expression. The time course of resveratrol treatment showed that 
application of 40 μM resveratrol enhanced protein abundance of both GluA1 and 
GluA2/3 from 1 hour to 8 hours. Changes of GluA1 and GluA2/3 peaked at 4 
hours with an increase of 152.2 ± 4.7% (n = 4, P < 0.01) and 132.4 ± 5.1% (n = 4, 
P < 0.01), respectively (Figure 4.1B). Resveratrol also led to a significant 
down-regulation of postsynaptic scaffolding protein, PSD95 (n = 3, p < 0.05) 
(Figure 4.1B). In contrast, resveratrol did not significantly alter the expression of 
the NMDA receptor subunit GluN1, indicating AMPAR-specificity of the resveratrol 
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effect. To investigate the resveratrol effect in vivo, we did intraperitoneal (IP) 
injection of resveratrol (30 mg/kg body weight) in mice (Wang et al., 2002). 
Consistent with the effect in vitro, a marked increase in AMPAR expression was 
observed 5 hours after resveratrol injection in all three brain regions including 
prefrontal cortex (PFC, 201.7 ± 4.0%, P < 0.01), hippocampus (Hippo, 138.7 
±11.4%, P < 0.01) and cerebellum (Cere, 224.5 ± 28.7%, P < 0.05) (n = 4 mice), 
comparing with the injection of vehicle control (Figure 4.1C). 
In addition to the total AMPAR protein levels, the amount of synaptic AMPARs 
were also increased following 4 hours resveratrol treatment, as evidenced by 
immunostaining of GluA1 together with PSD95 as a synaptic marker (130.2 ± 
2.9%, n = 50 cells, P < 0.01) (Figure 4.2A, D). Furthermore, surface biotinylation 
experiments utilizing cultured cortical neurons also showed that resveratrol 
treatment significantly increased the level of surface AMPARs (150.8 ± 5.8%, n = 
4, P < 0.01) (Figure 4.2B, D). As glutamatergic receptors mediate most of the 
excitatory synaptic transmission, changes in AMPAR expression are expected to 
alter synaptic function. To examine the functional impacts of resveratrol treatment, 
we analyzed AMPAR-mediated mEPSCs by whole-cell patch-clamp recordings in 
cultured hippocampal neurons. Compared with the vehicle control, 4-hour 
resveratrol treatment significantly increased the amplitude of mEPSCs (Ctrl: 10.9 
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± 0.5 pA; Resv: 13.7 ± 0.7 pA; 126.1 ± 4.8%, n = 8 cells, P < 0.01) (Figure 4.2C). 
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Figure 4.1 Resveratrol enhances AMPAR expression in neurons. 
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Figure 4.1 Resveratrol enhances AMPAR expression in neurons. (A) Western 
blots of cortical neurons treated with resveratrol at different dosage (10 - 40 μM) 
showing increased level of AMPAR GluA1 subunits. Resveratrol at 40 μM induced 
the most dramatic increase of GluA1. (B) Time course of resveratrol (40 μM, 1 – 8 
hr) treatment showed increased levels of AMPAR GluA1 and Glu2/3 subunits in 
cultured cortical neurons. No change was observed in the expression of NMDAR 
GluN1 subunits and tubulin. (C) I.P. injection of resveratrol (30 mg/kg body weight, 
5 hours) into C57BL/6 wild-type mice dramatically increased the total expression 
levels of AMPARs in PFC, hippocampus and cerebellum (n = 4), comparing with 
mice injected with vehicle control. Bar graphs represent mean ± S.E., ＊P < 
0.05. One-way ANOVA with Tukey post-hoc test (A, B) and Student’s two-tailed t 
test (C).  
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Figure 4.2 Resveratrol increases synaptic AMPAR expression and miniature 
transmission. 
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Figure 4.2 Resveratrol increases synaptic AMPAR expression and miniature 
transmission. (A, B, D) Synaptic staining or surface biotinylation of AMPARs 
showed resveratrol treatment (40 μM, 4 hours) significantly increased synapses 
(A, D) and cell-surface (B, D) localized GluA1. Surface GluN1 showed no change. 
PSD95 (A, green) was stained as the marker of excitatory synapses. Synaptic 
GluA1 puncta (A, red) overlapping with PSD95 were measured. Cell-surface 
AMPAR amount is quantified as the ratio of surface: total GluA1 (D). (C) 
Whole-cell voltage patch-clamp recording showed 4 hr resveratrol (40 μM) 
treatment significantly increased the average amplitude of the mEPSCs (126.1 ± 
4.8%, n = 8 cells, P < 0.01). This experiment was performed by collaborator 
James Gilbert from Biology department of Boston University. Bar graphs 
represent mean ± S.E., *P < 0.05, Student’s two-tailed t test.  
 
 
 
 
 
146 
 
4.3.2 Resveratrol increases AMPAR expression by facilitating receptor 
protein translation. 
Intracellular AMPAR levels are controlled by the dynamic balance between 
protein synthesis and degradation. Therefore, the observed resveratrol-induced 
increase in AMPAR expression levels may result from the suppression of receptor 
degradation and/or enhanced protein synthesis. To determine the involvement of 
protein degradation, we respectively inhibited two major degradation organelles: 
Leupeptin (Lep, 20 μM) (Figure 4.3A) to inhibit the lysosome and MG132 (MG, 10 
μM) (Figure 4.3B) to block proteasomal activity. While 4 hr treatment with each 
inhibitor individually resulted in a significant increase in AMPAR expression, none 
of the inhibitors occluded the resveratrol-induced AMPAR increase (Figure 4.3A, 
B). Moreover, resveratrol treatment in conjunction with the protein degradation 
inhibitors (Lep or MG) showed additive effects as compared to treatment with 
resveratrol or the inhibitors alone (Figure 4.3A, B). These results indicate that the 
effect of resveratrol on AMPAR protein expression is independent of receptor 
degradation. 
To examine the role of protein synthesis, we utilized the protein synthesis 
inhibitors cycloheximide (CHX, 100 μM) or anisomycin (Ani, 30 µM). Consistent 
with an effect on protein synthesis, the resveratrol-mediated increase in AMPAR 
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expression was abolished in either cycloheximide or anisomycin-treated neurons 
(Figure 4.4A, B). Next, we wanted to determine whether resveratrol altered 
AMPAR gene transcription. To this end, we pretreated neurons with actinomycin D 
(ActD, 25 μM) for 1 hr to block mRNA transcription. Unlike cycloheximide and 
anisomycin, ActD did not affect the resveratrol-induced increase in AMPARs 
(147.0 ± 10.9%, n = 4, P < 0.05) (Figure 4.5A). To directly examine AMPAR gene 
transcription, we performed RT-PCR to quantify GluA1 mRNA levels in cultured 
cortical neurons. As is shown in Figure 4.5B, GluA1 mRNA was not changed 
following resveratrol treatment (101.6 ± 6.1%, P > 0.05, n = 3). Together, these 
data indicate that resveratrol enhances AMPAR expression via up-regulation of 
receptor mRNA translation, without changing mRNA transcription or receptor 
degradation. 
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Figure 4.3 Resveratrol-induced AMPAR expression is protein degradation 
independent. 
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Figure 4.3 Resveratrol-induced AMPAR expression is protein degradation 
independent. Cortical neurons were incubated with resveratrol together with 
proteasome inhibitor MG132 (MG, 10 µM, n = 3)(A) or lysosome inhibitor 
leupeptin (Lep, 20 µM, n = 4)(B) to block protein degradation. Resveratrol effect 
on AMPAR expression persisted in the presence of the inhibitors (MG + Resv: 
172.3 ± 10.5%, n = 3, P < 0.05; Lep + Resv: 149.4 ± 10.8%, n = 4, P < 0.01). Bar 
graphs represent mean ±  S.E., ＊P < 0.05. One-way ANOVA with Tukey 
post-hoc test.  
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Figure 4.4 Resveratrol-induced AMPAR expression is dependent on 
enhanced protein synthesis. 
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Figure 4.4 Resveratrol-induced AMPAR expression is dependent on 
enhanced protein synthesis. Suppression of protein translation by 
cycloheximide (CHX, 100 µM) (A) or anisomycin (Ani, 30 µM) (B) completely 
abolished the resveratrol effect (CHX+Resv: 55.3 ± 11.0%, n = 4, P < 0.05; 
Ani+Resv: 63.6 ± 17.4%, n = 4, P < 0.05). Bar graphs represent mean ± S.E., 
＊P < 0.05. One-way ANOVA with Tukey post-hoc test.  
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Figure 4.5 Resveratrol does not affect AMPAR transcription. 
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Figure 4.5 Resveratrol does not affect AMPAR transcription. (A) Application 
of transcription inhibitor actinomycin D (ActD, 25 µM, n = 4) did not block the 
resveratrol effect on AMPARs. (B) RT-PCR showed that 4 hr resveratrol treatment 
(40 µM) did not change the expression level of GluA1 mRNA. Bar graphs 
represent mean ± S.E., *P < 0.05. Bar graphs represent mean ± S.E., ＊P < 
0.05. One-way ANOVA with Tukey post-hoc test (A) and Student’s two-tailed t test 
(B).  
 
 
 
 
 
 
 
 
 
154 
 
4.3.3 Resveratrol regulates AMPAR expression in a SIRT1-independent 
manner 
As a well-known activator of the sirtuin family (Dal-Pan et al., 2011; Howitz et 
al., 2003; Smith et al., 2009), resveratrol’s effects have often been shown to be 
mediated by the sirtuins (Baur and Sinclair, 2006; Pallas et al., 2009). Therefore, 
we hypothesized that the observed effects of resveratrol on AMPAR expression 
were also mediated by the sirtuins. Among the seven members of mammalian 
sirtuins (SIRT1-7), resveratrol primarily targets SIRT1 (Baur and Sinclair, 2006; 
Witte et al., 2009). In cultured cortical neurons, the SIRT1-specific inhibitor EX527 
(1.2 µM) (Napper et al., 2005) was applied 1 hour prior to and during resveratrol 
treatment. Surprisingly, in the presence of EX527, resveratrol remained to be able 
to increase GluA1 protein expression to a level similar to that of resveratrol alone 
(Figure 4.6A). Also, EX527 treatment alone did not have significant effect on 
GluA1 expression (n = 4, P > 0.05) (Figure 4.6A). 
To exclude any potential side effects of EX527, we utilized a siRNA directed 
against SIRT1 (siSIRT1) to specifically knockdown endogenous SIRT1. 
Compared to the scrambled siRNA control, expression of siSIRT1 dramatically 
decreased endogenous SIRT1 levels in hippocampal neurons and HEK 293T 
cells (22.3 ± 7.3%, n = 4, P < 0.01) (Figure 4.6B). In hippocampal neurons 
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co-transfected with siSIRT1 and EGFP, resveratrol significantly increased 
synaptic GluA1 accumulation (132.3 ± 6.5%, n = 18 cells, P < 0.05) while siSIRT1 
itself had no effect on synaptic GluA1 (n = 18 cells, P > 0.05) (Figure 4.6C). These 
data demonstrate that resveratrol up-regulates AMPAR protein expression via a 
SIRT1-independent mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
156 
 
Figure 4.6 Resveratrol-induced AMPAR up-regulation is independent of 
SIRT1 activity. 
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Figure 4.6 Resveratrol-induced AMPAR up-regulation is independent of 
SIRT1 activity. (A) SIRT1-specific inhibitor EX527 (1.2 µM) treatment did not 
affect resveratrol-induced increase in AMPAR amount. (B) Hippocampal neurons 
or HEK 293T cells were transfected with EGFP together with SIRT1-specific 
siRNA (siSIRT1) or a scrambled control (siScramble). Immunostaining (left panel) 
or blotting (right panel) of endogenous SIRT1 showed significantly reduced 
expression in cells transfected by siSIRT1 (22.3 ± 7.3%, n = 4, P < 0.01). (C) 
GluA1 (red) was immunostained in hippocampal neurons transfected with EGFP 
together with siSIRT1 or siScramble. Knockdown of SIRT1 by siRNA did not affect 
the resveratrol effect on AMPAR expression. Bar graphs represent mean ± S.E., 
＊P < 0.05. One-way ANOVA with Tukey post-hoc test (A) and Student’s 
two-tailed t test (B, C). 
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4.3.4 Resveratrol up-regulates AMPARs through activating AMPK and 
PI3K/Akt pathways 
In addition to SIRT1 activation, resveratrol has also been shown to target 
AMPK (Dasgupta and Milbrandt, 2007). Resveratrol exerts certain physiological 
effects via stimulating AMPK activity, such as improving mitochondrial function 
and glucose tolerance (Chung et al., 2012). However, whether the 
resveratrol-AMPK pathway exists in neurons remains unclear. To examine this 
cascade, we probed phosphorylated AMPK at Thr172, an indicator of AMPK 
activation. We found that resveratrol (1-8 hours) incubation significantly increased 
the level of AMPK Thr172 phosphorylation without affecting total AMPK protein 
levels (Figure 4.7), indicating that resveratrol causes AMPK activation in neurons. 
The temporal profile of AMPK phosphorylation also matched the changes in 
AMPAR expression (Figure 4.1B and Figure 4.7). 
AMPK is coupled to a large number of downstream effectors (Hardie, 2007), 
among which PI3K/Akt is one of the major signaling cascades. PI3K/Akt signaling 
plays a critical role in protein synthesis and growth (Schratt et al., 2004), and is 
involved in AMPAR trafficking and synaptic plasticity (Man et al., 2003). Our 
recent work has demonstrated that in neurons PI3K/Akt serves as the signaling 
cascade downstream of AMPK (Amato et al., 2011). To examine the possibility 
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that resveratrol regulates the PI3K/Akt pathway via AMPK activation, we probed 
resveratrol-treated neuronal lysates with an antibody specific for phosphorylated 
Akt at Ser473, a hallmark of Akt activation and thus an indicator for PI3K activity 
(Sarbassov et al., 2005). Indeed, we observed a direct correlation between AMPK 
phosphorylation and the time-dependent increase in Akt phosphorylation with 
resveratrol treatment (Figure 4.7). 
To further confirm the involvement of AMPK in resveratrol effects on AMPAR 
expression, we first used the specific AMPK inhibitor, Compound C (CC, 20 µM), 
to block AMPK activity in neurons. Treatment with CC abolished both 
resveratrol-induced AMPAR increases and AMPK phosphorylation (Figure 4.8A). 
In support of PI3K as the effector downstream of AMPK, treatment of cortical 
neurons with the specific PI3K inhibitor, LY294002, blocked resveratrol-induced 
Akt phosphorylation and GluA1 increases (Figure 4.8B). 
To further confirm the involvement of the AMPK-PI3K-Akt system, in cultured 
hippocampal neurons we overexpressed a kinase dead form of AMPKα1 subunit 
(AMPK K.D., D157A point mutation) and a dominant negative PI3K mutant (PI3K 
D.N.) to suppress endogenous AMPK or PI3K activity, respectively. 
Overexpression of AMPK K.D. significantly decreased the synaptic GluA1 
accumulation and completely abolished resveratrol-induced increases in GluA1 
160 
 
synaptic accumulation (Figure 4.8C). Similar to AMPK K.D., overexpression of 
PI3K D.N. in hippocampal neurons also markedly decreased synaptic GluA1 
accumulation and blocked resveratrol-induced increase in GluA1 synaptic 
accumulation (Figure 4.8C). In contrast, control cells expressing only EGFP 
showed a significant increase in GluA1 expression in response to resveratrol 
treatment (Figure 4.8C). In line with the dominant negative effect of the mutant 
AMPK or PI3K, overexpression of AMPK K.D. or PI3K D.N. in HEK cells 
dramatically reduced AMPK or Akt phosphorylation levels, respectively (data not 
shown). 
Previous studies have implicated calcium/calmodulin-dependent kinase 
kinase β (CaMKKβ) as the upstream activator of AMPK (Hawley et al., 2005). By 
using the fluorescent calcium indicator protein G-CaMP3 (Hou et al., 2011; Nakai 
et al., 2001), we monitored changes of intracellular calcium in transfected 
hippocampal neurons. 4-hour incubation with resveratrol caused a marked 
increase in G-CaMP3 intensity, indicating an elevation of intracellular calcium 
(Figure 4.9A). Furthermore, to determine the involvement of CaMKK in the 
resveratrol-mediated effect, we used the specific CaMKK inhibitor, STO609. 
When STO609 (STO, 40 μM) was applied for 1 hour prior to and during 
resveratrol treatment, resveratrol-induced AMPK phosphorylation and the 
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subsequent increase in AMPAR abundance were completely abolished (Figure 
4.9B). Moreover, STO609 alone caused a decrease in AMPAR abundance, 
indicating that the constitutive activity of CaMKK is important in the maintenance 
of AMPAR proteostasis. 
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Figure 4.7 Resveratrol activates AMPK and PI3K/Akt signaling cascades in 
cultured neurons.  
 
 
 
 
163 
 
Figure 4.7 Resveratrol activates AMPK and PI3K/Akt signaling cascades in 
cultured neurons. Western blot analysis of resveratrol-treated cortical neurons. 
Resveratrol caused time-dependent phosphorylation (and activation) of AMPK 
and Akt. Total AMPK, Akt and tubulin showed no change (Upper panel: western 
blot bands; lower panel: quantifications of the pAMPK and pAKT signals 
normalized to the total protein levels). Bar graphs represent mean ± S.E., ＊P < 
0.05. One-way ANOVA with Tukey post-hoc test. 
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Figure 4.8 Blockade of AMPK or PI3K/Akt signaling pathways abolishes 
resveratrol effect on AMPAR expression. 
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Figure 4.8 Blockade of AMPK or PI3K/Akt signaling pathways abolishes 
resveratrol effect on AMPAR expression. (A, B) Cortical neurons were treated 
with resveratrol in the presence of AMPK inhibitor Compound C (CC, 20 μM) or 
PI3K inhibitor LY 294002 (LY, 20 µM), respectively. Resveratrol effect on AMPAR 
expression was abolished by each individual inhibitor. n = 4 each, *P < 0.05. (C) 
GluA1 was immunostained (red) in neurons transfected with EGFP plus kinase 
dead AMPK (AMPK K.D.) or dominant negative PI3K (PI3K D.N.). No increases in 
GluA1 puncta intensity by resveratrol was detected in cells expressing AMPK K.D. 
or PI3K D.N. while normal response was observed in pcDNA transfected cells. 
Bar graphs represent mean ± S.E., ＊P < 0.05. One-way ANOVA with Tukey 
post-hoc test (A, B) and Student’s two-tailed t test (C). 
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Figure 4.9 Resveratrol activates AMPK pathway by increasing intracellular 
calcium level and CAMKK pathway signaling.  
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Figure 4.9 Resveratrol activates AMPK pathway by increasing intracellular 
calcium level and CAMKK pathway signaling. (A) G-CaMP3 imaging in live 
hippocampal neurons showed 47.8 ± 10.0% (n = 13 cells, P < 0.05) an increase in 
average fluorescent intensity in resveratrol-treated (40 µM for 4 hours) 
hippocampal neurons as compared to DMSO-treated (1:1000 for 4 hours) control 
neurons. (B) CaMKK inhibitor STO609 (STO, 40 µM) pre-treatment abolished 
resveratrol-induced GluA1 increase and AMPK phosphorylation. Bar graphs 
represent mean ± S.E., ＊P < 0.05. Student’s two-tailed t test (A) and One-way 
ANOVA with Tukey post-hoc test (B).  
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4.3.5 Involvement of the eIF4F translation initiation complex in 
resveratrol-induced increases in AMPARs 
Our data indicated an involvement of protein synthesis in resveratrol-induced 
increase in AMPAR expression, however the molecular details surrounding the 
translational regulation of AMPARs remain unclear. In eukaryotes, an important 
initiation step in protein translation is the recruitment of the ribosome to the mRNA, 
an action which requires proper assembly of the eukaryotic initiation factor 4F 
(eIF4F) complex (Sonenberg and Hinnebusch, 2009). eIF4F is assembled by the 
cap-binding protein eIF4E, eIF4A and the scaffolding protein eIF4G. Also involved 
is the endogenous translation repressor, 4E-BP, that binds to eIF4E and prevents 
the formation of the eIF4F complex. Interestingly, 4E-BP has been implicated in 
protein synthesis required for long-term potentiation (L-LTP) (Banko et al., 2005) 
and in the PI3K/Akt signaling pathway (Sonenberg and Hinnebusch, 2009), 
suggesting a potential role for eIF4F complex in resveratrol-induced AMPAR 
translation. To test this possibility, we first investigated whether resveratrol 
regulates the expression of the initiation complex components. As shown in 
Figure 4.10A, resveratrol treatment significantly increased both eIF4E and eIF4G 
levels. Moreover, overnight pretreatment with the eIF4E-4G interaction inhibitor, 
4EGI-1 (22 µM), completely abolished the resveratrol-induced AMPAR increase 
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(Figure 4.10B). LY pretreatment completely blocked resveratrol-induced eIF4E 
and 4G up-regulation (n = 3 of each, Figure 4.10C), indicating that the resveratrol 
effect on the initiation complex resulted from resveratrol-dependent signaling. 
These data strongly indicated the requirement of the eIF4F complex activity in 
resveratrol-stimulated AMPAR synthesis. 
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Figure 4.10 Involvement of the translation initiation complex eIF4F in 
resveratrol-induced AMPAR up-regulation. 
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Figure 4.10 Involvement of the translation initiation complex eIF4F in 
resveratrol-induced AMPAR up-regulation. (A) Resveratrol treatment 
significantly increased protein levels of both eIF4E and eIF4G, as well as GluA1. 
Tubulin as a control showed no change. (B) Application of a specific eIF4E and 
4G interaction blocker 4EGI-1 (22 µM) abolished resveratrol-induced AMPAR 
increase (n = 4, P < 0.05). (C) Application of PI3K inhibitor LY blocked 
resveratrol-induced eIF4E and 4G up-regulation (n = 3 of each, P < 0.05). Bar 
graphs represent mean ± S.E., ＊P < 0.05. Student’s two-tailed t test (A) and 
One-way ANOVA with Tukey post-hoc test (B, C). 
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4.3.6 Pharmacological activation of AMPK mimics the effects of resveratrol 
Our data indicate that AMPK is the primary upstream effector in the 
resveratrol-induced molecular events. If so, activation of AMPK is expected to 
mimic the resveratrol effects. To test this notion, we utilized a conventional AMPK 
activator, AICAR, to specifically activate the AMPK pathway in neurons (Amato et 
al., 2011). Similar to resveratrol, AICAR treatment (2 mM, 2-4 hours) significantly 
increased total amount of GluA1 and the level of AMPK phosphorylation (Figure 
4.11A). Consistent with this, AICAR treatment significantly increased Akt 
phosphorylation and the protein amounts of eIF4E/G (Figure 4.11A). Similar to 
resveratrol, the AICAR-induced GluA1 increase was also blocked by the protein 
synthesis inhibitors cycloheximide (n = 3) and anisomycin (n = 3)(Figure 4.11B) 
and was occluded by resveratrol co-application (n = 4) (Figure 4.12A). 
Furthermore, both the AMPK inhibitor CC (20 µM) and PI3 kinase inhibitor LY (20 
µM) blocked an AICAR-induced increase in GluA1 (Figure 4.12B, C). All together 
these data show that AICAR utilizes a similar molecular mechanism as resveratrol 
to increase AMPAR expression in neurons. Interestingly, while LY dramatically 
inhibited Akt phosphorylation on Ser 473, it did not affect AICAR-caused AMPK 
activation, indicating that the PI3K-Akt signaling cascade lies downstream of 
AMPK (Figure 4.12C). 
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Figure 4.11 AICAR treatment activates AMPK-PI3K signaling pathway and 
increases AMPAR synthesis as resveratrol does. 
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Figure 4.11 AICAR treatment activates AMPK-PI3K signaling pathway and 
increases AMPAR synthesis as resveratrol does. (A) In cultured cortical 
neurons, activation of AMPK by AICAR (2 mM) led to an increase in GluA1, eIF4E, 
eIF4G, and the activation of AMPK (pAMPK) and Akt (pAkt) pathways. (B) 
AICAR-induced AMPAR increase was blocked by protein synthesis inhibitor 
cycloheximide (CHX, 100 µM) (n = 3) or anisomycin (Ani, 30 µM) (n = 3). Bar 
graphs represent mean ±  S.E., ＊P < 0.05. One-way ANOVA with Tukey 
post-hoc test (A) and Student’s two-tailed t test (B).  
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Figure 4.12 AICAR utilizes the same pathways as resveratrol to increase 
AMPAR expression in cultured neurons.  
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Figure 4.12 AICAR utilizes the same pathways as resveratrol to increase 
AMPAR expression in cultured neurons. (A) Cortical neurons were treated with 
resveratrol or together with AICAR. In the presence of AICAR, no further increase 
in GluA1 amount was induced by resveratrol (n = 4). (B, C) AICAR effect on 
AMPAR increase was blocked by either AMPK inhibitor CC (20 µM) (n = 3) or 
PI3K inhibitor LY 294002 (LY, 20 µM) (n = 3). Bar graphs represent mean ± S.E., 
＊P < 0.05. One-way ANOVA with Tukey post-hoc test. Parts of the data in B, C 
were contributed by collaborator Stephen Amato from Biology department of 
Boston University.  
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4.4 Discussion 
In this study, I showed that resveratrol treatment can rapidly increase AMPAR 
expression in neurons. More specifically, resveratrol induces AMPAR protein 
translation without affecting its mRNA transcription or protein degradation. 
Resveratrol causes intracellular Ca2+ increase in neurons and activates CaMKKβ, 
leading to the activation of AMPK pathway, which consequentially up-regulates 
PI3K/Akt pathway activity as well as eIF4E/4G-mediated AMPAR protein 
translation. AMPARs play crucial roles in synaptic transmission and plasticity. 
Therefore, AMPAR expression and synaptic transmission may play an important 
role in mediating resveratrol’s beneficial effects in brain functions including 
learning, memory and cognition. 
SIRT1 has conventionally been thought to be the target of resveratrol to exert 
its promiscuous biological effects (Baur and Sinclair, 2006). However, AMPK has 
also been found to play important roles in mediating the effects of resveratrol 
recently (Cho et al., 2014; Chung et al., 2012). Consistent with this, I found the 
AMPK signaling pathway, but not SIRT1, is required for resveratrol-mediated 
AMPAR up-regulation. For the first time, we show a regulatory relationship 
between the bioenergy sensor AMPK and AMPAR. It may help explain many 
beneficial effects that resveratrol possesses to the brain. The energy-lacking 
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condition of human body like calorie restriction (CR) is a good example. CR is 
known to activate AMPK pathway as well as benefits in cognitive improvements 
and mental health (Gillette-Guyonnet and Vellas, 2008; Witte et al., 2009). The 
involvement of AMPK in CR is particularly interesting. AMPK activation stimulates 
mitochondrial biogenesis and positive regulation on metabolism that contribute to 
CR (Canto and Auwerx, 2011). CR is also the most consistent intervention that 
can increase life span and improve ageing-related cognitive deteriorations in 
animals (Dal-Pan et al., 2011; Fontana et al., 2010). Resveratrol is an established 
CR mimetic that possesses all these effects as well (Chung et al., 2012). It will be 
interesting to investigate whether CR can lead to enhanced AMPAR synthesis 
similar to the resveratrol effect. 
Resveratrol is well known for being protective to neurons from pathological 
cell death (Chung et al., 2011; Fukui et al., 2010; Gupta et al., 2002; Sinha et al., 
2002; Tsai et al., 2007; Wang et al., 2002). However, the underlying molecular 
mechanisms remain largely unclear. I found that resveratrol activates the 
PI3K/Akt signaling pathway via the AMPK pathway. The PI3K/Akt pathway is well 
known for its cell protection (Jo et al., 2012), our findings provide insight into a 
novel mechanism of resveratrol-mediated neuroprotection.  
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CHAPTER FIVE 
Discussion and future perspectives 
 
 
 
 
 
 
180 
 
5.1 Summary 
In this dissertation, I demonstrate that AMPARs are subject to lysine 
acetylation as a novel PTM. Acetylation has been considered a modification 
mainly for nuclear histone proteins, although recently a few other cytosolic 
proteins including tubulin, AMP-activated protein kinase (AMPK) and tau have 
also been recognized as substrates (Lu et al., 2011; Min et al., 2010; North et al., 
2003). We find that the GluA1 subunit of AMPAR has high levels of acetylation 
under basal conditions, which can be efficiently regulated by SIRT2. Through 
competition for the lysine sites at the GluA1 C-terminus, acetylation and 
ubiquitination of AMPARs reach a balance in order to maintain receptor 
proteostasis (Caron et al., 2005). Deacetylation of AMPARs by the brain-enriched 
SIRT2 facilitates receptor ubiquitination, leading to receptor internalization and 
proteasomal degradation (Figure 5.1). Therefore, alterations in SIRT2 expression 
and/or its enzymatic activities may be of crucial importance for AMPAR turnover, 
synaptic plasticity and cognitive brain function. 
In addition, I investigated the effect of resveratrol on AMPAR expression and 
the underlying molecular mechanisms in primary neurons. I show that resveratrol 
increases AMPAR expression in neurons. Specifically, resveratrol stimulates 
receptor protein translation without affecting receptor mRNA transcription or the 
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rate of protein degradation. Upstream of the signaling cascade, resveratrol 
causes an elevation of intracellular Ca
2+
 and activation of CaMKKβ, leading to the 
activation of AMPK. Consistent with our previous findings (Amato et al., 2011), 
AMPK activation results in up-regulation of the downstream PI3K/Akt pathway, 
leading to eIF4E/4G-mediated AMPAR protein translation (Figure 5.2). Given the 
crucial role for AMPARs in synaptic activity and plasticity, elevated AMPAR 
expression and synaptic transmission may play an important role in mediating 
resveratrol’s beneficial effects in brain functions including learning, memory and 
cognition. 
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Figure 5.1 A schematic illustration depicting the competing processes 
between GluA1 acetylation and ubiquitination as well as their relationship to 
protein trafficking and degradation. 
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Figure 5.1 A schematic illustration depicting the competing processes 
between GluA1 acetylation and ubiquitination as well as their relationship to 
protein trafficking and degradation. With the loss of SIRT2, GluA1 is 
over-acetylated which protects against the binding of ubiquitin. Acetylation 
prevents GluA1 from being recognized by the proteolysis machinery that leads to 
AMPAR internalization and degradation. Conversely, with the presence of SIRT2, 
the acetyl groups are removed, leaving the lysine residues available for the 
binding of ubiquitins, leading to proteolysis and protein degradation. 
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Figure 5.2 A schematic illustration of the signaling cascades underlying 
resveratrol-induced AMPAR up-regulation. 
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Figure 5.2 A schematic illustration of the signaling cascades underlying 
resveratrol-induced AMPAR up-regulation. Resveratrol increases intracellular 
calcium level that leads to the activation of CaMMKβ and consequently the AMPK 
pathway. AMPK activates its downstream PI3K/Akt signaling cascades and 
eIF4E/G complex, leading to an enhanced translation of AMPAR subunits. 
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5.2 Acetylation and its implications in AMPAR regulation, cognitive 
functions and Alzheimer’s disease.  
5.2.1 Stabilization of AMPAR by acetylation in neurons 
Accumulation of AMPARs at the post-synaptic surface is important for 
neurons to ensure stable synaptic transmission, which serves as the foundation 
for normal cognitive functions. Amongst the currently described three PTMs of 
AMPAR, phosphorylation and palmitoylation mainly influence the receptor 
channel conductance and intracellular trafficking while ubiquitination serves as 
the signal for receptor internalization and degradation (Lu and Roche, 2012a). 
The lysine acetylation we identified on AMPAR is not only novel but also the first 
PTM known to enhance the general receptor stability and stabilization on the cell 
membrane. Considering the crucial role of surface AMPAR stability in synaptic 
transmission and brain function, it is natural to speculate about the potential 
physiological importance of AMPAR acetylation.  
The best known and studied mechanism utilized by acetylation to stabilize 
AMPAR stability is that it competes directly for the lysine residues with 
ubiquitination. Protein ubiquitination refers to the biochemical process of 
ubiquitins or poly-ubiquitin chains attachment to the lysine residues of a peptide. 
Ubiquitinated peptides will be further captured by the intracellular proteolysis 
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machineries that lead to the degradation of the target proteins. Therefore, when 
AMPARs are acetylated, it protects the lysine residues from being ubiquitinated 
and slows down the receptor protein degradation process. In my study, I observed 
a clear competition between AMPAR acetylation and ubiquitination in cultured 
neurons. When AMPAR acetylation or ubiquitination is enhanced, the counterpart 
modification is down-regulated (Figure 3.7A-C). This competition is also occurring 
naturally during the course of in vitro neuron development. When cultured 
neurons mature, there is a gradually enhancement in AMPAR ubiquitination 
accompanied with a corresponding down-regulation in receptor acetylation 
(Figure 3.7D). This competition provides a molecular mechanism that acetylation 
protects the protein from being ubiquitinated and degraded.  
5.2.2 Increased AMPAR dynamics and decreased acetylation during 
neurons maturation 
 During synaptogenesis and the formation of neural network, AMPARs need to 
be synthesized and inserted onto the post-synaptic surface to ensure the normal 
functioning of the glutamatergic synapses. This process requires the stabilization 
of AMPARs. Therefore, I expected to see enhancement of AMPAR acetylation 
during this process. However, in contrast, down-regulated AMPAR acetylation and 
enhanced ubiquitination were observed in mature neurons, which indicates 
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reduced instability of AMPAR compared to immature neurons. One explanation to 
this phenomenon is that maintaining a certain rate of AMPAR dynamics and 
recycling in neurons is as crucial as its stability for normal synaptic transmission 
and plasticity (Malinow and Malenka, 2002; Shepherd and Huganir, 2007). 
Therefore, in order to reach the desired intracellular dynamics of AMPAR, neurons 
may actively up-regulate its ubiquitination which passively lead to acetylation 
down-regulation. Meanwhile, the lowered acetylation needs to be adequate to 
maintain the basic stability of AMPAR in the mature neurons. 
5.2.3 Increased acetylation of AMPAR impairs synaptic plasticity and 
memory 
Functional studies confirmed that lowering AMPAR acetylation to a proper 
level is essential for maintaining the receptor dynamics and synaptic plasticity. I 
expected to see potentiated synaptic plasticity and learning memory when total 
expression and synaptic accumulation of AMPARs were elevated after SIRT2 
deletion. However, my functional studies showed the opposite results: both 
synaptic plasticity (LTP/LTD) and different memories are impaired (spatial, fear 
learning and memories). While the LTP is only modestly impaired, the LTD is 
almost completely abolished (Figure 3.18C, D). This is consistent with the major 
function of acetylation that stabilizes AMPARs on the cell surface and slows down 
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its internalization. AMPAR internalization is well-known as a crucial step of LTD 
while LTP demands more receptors insertion other than internalization (Beattie et 
al., 2000; Malinow, 2003).  
5.2.4 Interaction between acetylation and phosphorylation.  
 Protein acetylation not only competes with ubiquitination but also interacts 
with other PTMs such as phosphorylation. Depending on the protein 
conformational changes it triggers, protein acetylation may facilitate or inhibit the 
phosphorylation. For example, acetylation of tau facilitates, while AMPK 
acetylation inhibits their phosphorylation respectively (Lin et al., 2012; Min et al., 
2010). Similarly, I observed a one-way interaction between AMPAR acetylation 
and phosphorylation. Increased AMPAR acetylation enhances its phosphorylation 
while no clear changes have been observed the other way around (Figure 3.8A, 
B). This interaction implies significant physiological functions of acetylation since 
phosphorylation is one of the most important PTMs of AMPARs. Changes related 
to AMPAR phosphorylation is directly associated with synaptic transmission, 
plasticity and cognitive functions (Lee et al., 2003; Shepherd and Huganir, 2007). 
Facilitation of AMPAR phosphorylation by acetylation indicates a mechanism that 
these two PTMs may work in coordination to promote the insertion and stability of 
AMPARs at the postsynaptic terminals.  
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5.2.5 SIRT2, AMPAR acetylation and Alzheimer’s disease.  
 SIRT2 has been shown to be involved in several nervous system diseases 
including Parkinson disease, gliomagenesis and axon degeneration (Garske et al., 
2007; Harting and Knoll, 2010; Outeiro et al., 2007). Inhibition of SIRT2 function 
rescues certain symptoms of these diseases. In my study, I found SIRT2 and 
AMPAR acetylation may also be involved in the development of Alzheimer’s 
disease pathology. Treatment of neurons by the Aβ oligomers increases the 
expression of SIRT2 in neurons (data not shown) and consistent with this, I 
observed decreased AMPAR acetylation in different brain tissues (prefrontal 
cortex and hippocampus) from AD patients (Figure 3.23). It is known that AMPAR 
down-regulation is an early molecular alteration of AD and Aβ oligomers triggers 
AMPAR internalization and degradation, which may be the mechanism of early 
memory loss during AD developmental course (Chang et al., 2006; Hsieh et al., 
2006). Decreased AMPAR acetylation and enhanced SIRT2 expression provide a 
possible explanation of AMPAR down-regulation as well as a potential 
pharmaceutical treatment targets for AD pathology.  
5.3 Regulation of AMPAR abundance by resveratrol via AMPK-PI3K- 
eIF4E/4G signaling cascades in neurons 
5.3.1 Regulation of AMPAR abundance by the AMPK pathway 
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Resveratrol has conventionally been thought to activate SIRT1 to achieve its 
promiscuous biological effects (Baur and Sinclair, 2006). However, recent studies 
have demonstrated that AMPK, another downstream effector of resveratrol, also 
plays an important role in mediating the effects of resveratrol (Cho et al., 2014; 
Chung et al., 2012). In line with this, we find that the AMPK signaling pathway, but 
not SIRT1, is required for resveratrol-mediated AMPAR up-regulation. As one of 
the most important excitatory receptors in the brain, the abundance and turnover 
of AMPARs are highly regulated by many different molecules and signaling 
pathways. For the first time, we show a link between the bioenergy sensor AMPK 
and AMPAR regulation. These findings may further explain many beneficial 
effects that resveratrol imparts to the brain. Specifically, energy-lacking conditions 
such as calorie restriction (CR) or physical exercise that often activate AMPK are 
known to be implicated in cognitive improvements and mental health 
(Gillette-Guyonnet and Vellas, 2008; Witte et al., 2009). The involvement of AMPK 
in CR is especially interesting. AMPK contributes to CR by stimulating 
mitochondrial biogenesis and positive regulation on metabolism (Canto and 
Auwerx, 2011). CR is also the most consistent intervention that can increase life 
span and improve ageing-related cognitive deteriorations in animals (Dal-Pan et 
al., 2011; Fontana et al., 2010). In line with this notion, resveratrol is an 
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established CR mimetic that possesses all these effects as well (Chung et al., 
2012). It will be interesting to investigate whether CR itself can also enhance 
AMPAR synthesis similar to the resveratrol effect. 
5.3.2 PI3K/Akt pathway and neuroprotection with resveratrol 
Resveratrol is well known for protecting neurons from cell death under many 
pathological conditions in the brain (Chung et al., 2011; Fukui et al., 2010; Gupta 
et al., 2002; Sinha et al., 2002; Tsai et al., 2007; Wang et al., 2002). However, the 
underlying mechanisms mediating the neuroprotective effect remain less clear. In 
our study, we find that resveratrol activates the PI3K/Akt signaling pathway via 
activation of AMPK. Given the crucial role of the PI3K/Akt pathway in cell 
protection (Jo et al., 2012), our findings provide insight into a novel mechanism of 
resveratrol-mediated neuroprotection. Intriguingly, unlike what is observed in 
neurons, resveratrol inhibits the PI3K/Akt pathway in many peripheral tissues 
(Poolman et al., 2005; Venkatachalam et al., 2008). The tissue type specificity 
may explain why resveratrol’s protective role occurs exclusively in neurons. 
5.3.3 eIF4E/4G-mediated regulation of AMPAR translation 
I provide the first evidence indicating a direct role for the translation initiation 
complex in AMPAR translation. In agreement with our findings, a recent study has 
revealed that knock-out of 4E-BP, the endogenous inhibitor of the eIF4F complex, 
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resulted in an increase in AMPARs (Ran et al., 2013). Interestingly, the expression 
of NMDARs, another type of glutamate receptor usually co-localizing with 
AMPARs, is not affected by resveratrol. It is not clear how neurons achieve the 
specificity on AMPARs. Possibly, certain regulatory components other than the 
core eIF4F subunits participate in the initiation process, which may determine the 
specificity in the selection of target mRNAs. 
I find that resveratrol up-regulates total and synaptic AMPARs due to 
facilitated protein translation, however, the subcellular sites of resveratrol’s effects 
remain unclear. Changes in local AMPAR levels could result from intracellular 
receptor trafficking or local protein synthesis, or both. Thus, in addition to the cell 
body, resveratrol may regulate AMPAR local synthesis in the dendrites. Indeed, 
mRNAs of AMPAR subunits reside in the dendrites and spines and are subjected 
to activity-dependent local synthesis (Grooms et al., 2006). Furthermore, dendritic 
localization has been shown for the signaling molecules involved in the effects of 
resveratrol, including AMPK, PI3K/Akt (Potter et al., 2010; Yoshii and 
Constantine-Paton, 2007) and the protein translation machinery including the 
eIF4E/4G elongation complex (Takei et al., 2004). Given the requirement of 
mRNA translation, probably of AMPARs, in late-LTP (Bramham, 2008; Gobert et 
al., 2008), it is intriguing whether resveratrol can facilitate or enhance the 
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expression of LTP, which may also be implicated in resveratrol’s beneficial role in 
brain function. 
5.4 Conclusions and perspectives 
 In this dissertation, I identified two novel mechanisms, via different molecular 
signaling pathways, that the protein dynamics and trafficking of AMPARs were 
being regulated in neurons. In one part, I identified that in addition to the other 
PTMs (e.g. phosphorylation, ubiquitination), AMPARs are subject to another PTM, 
lysine acetylation, which significantly influences the intracellular stability, 
dynamics and trafficking of the receptor protein, and consequentially, the synaptic 
transmission and even upper-level cognitive functions of the brain. I found that the 
NAD+-dependent protein deacetylase, SIRT2, is the deacetylase of AMPAR that 
controls its acetylation level and AMPAR-related brain functions. This finding 
provides new insights into the intracellular regulatory mechanisms of AMPAR and 
explanations of some phenomena that can not be readily explained by existing 
theories. For example, although stabilizing AMPARs in neuron is one of the most 
crucial steps to maintain the normal synaptic transmission, none of the known 
PTMs of AMPAR functions as a direct mechanism to stabilize AMPAR in neurons. 
Acetylation is the first known molecular mechanism that can directly stabilize 
AMPAR in neurons. In addition, the connection between this finding to 
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aging-related mental deteriorations (e.g. AD) provides a new potential mechanism 
of AD pathology as well as a therapeutic target for AD treatment. Loss of AMPARs 
is one of the most representative early-onset symptoms of AD pathology. Since 
Aβ oligomers result in SIRT2 up-regulation and AMPAR down-regulation, it is 
possible Aβ oligomers cause AMPAR loss by decreasing the receptor acetylation. 
Blocking this process may be able to rescue the Aβ oligomers-induced AMPAR 
loss during early onset of AD.  
In the other part, I found the phytoalexin resveratrol, which is a widely-used 
food supplement, can enhance the expression of AMPAR in neurons, by 
stimulating AMPK-PI3K pathway-dependent protein synthesis, rather than 
slowing-down the receptor protein degradation. Enhanced AMPAR synthesis 
results in enhanced synaptic AMPAR accumulation and surface expression, as 
well as strengthened synaptic transmission. This finding provides a new 
molecular mechanism to explain the promiscuous physiological effects resveratrol 
possesses in central nervous system, especially its neuroprotective effects. 
AMPK activation is known to suppress the PI3K/Akt pathway activity in other 
tissues. However, I found rather than to inhibit, activation of AMPK by resveratrol 
in neurons leads to increased PI3K/Akt activity, which is well-known for its 
neuroprotective effects. Resveratrol is also well-known for effects of anti-aging 
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related mental deteriorations (e.g. dementia, AD) effect. The stimulation of 
AMPAR synthesis by resveratrol may provide a new explanation to this rescuing 
effect since AMPAR down-regulation is one of the best known symptoms during 
the course of aging (Lu et al., 2004).  
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